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ABSTRACT 
Fatigue and exercise intolerance are common symptoms experienced by patients with chronic 
heart failure (CHF). Historically it has been argued that central cardiopulmonary factors including 
pulmonary congestion and reduced lung compliance cause dyspnoea that limits the exercise 
tolerance of such patients. But recent studies have indicated that exercise capacity in patients with 
CHF may not be limited solely by central cardiorespiratory factors. Rather the focus has shifted to 
aspects of the peripheral circulation and skeletal muscle function as possible factors limiting the 
exercise tolerance of patients with CHF. However there are few studies describing both the 
structural and functional abnormalities in the skeletal muscle of patients with CHF. 
In the first study of this dissertation, 11 patients with end-stage heart failure (NYHA class Ill-IV) and 
10 healthy control subjects (C) underwent i) graded exercise to exhaustion for determination of 
peak oxygen consumption (V02 peak) and peak work load (Wlpeak); ii) isometric and isokinetic 
tests of skeletal muscle function and iii) radionuclide angiography for determination of ejection 
fraction (EF% ). 
V02 peak (12.5 ± 1.0 vs 34.3 ± 3.5 ml02fkg/min; p<0.001), Wlpeak (73 ± 10 vs 224 ± 14 W; 
p<0.001 ), total work performed by the quadriceps muscles (TWQ) in a 30 sec isokinetic test 
(TWQ; 1565 ± 166 vs 2892 ± 345 J; p<0.05), and hamstring muscles (TWH) (TWH; 604 ± 163 vs 
2003 ± 326 J; p<0.05), maximum voluntary isometric contraction (MVC) of the quadriceps muscles 
(MVC; 134 ± 12 vs 194 ± 11 Nm; p<0.001) and isokinetic peak torque of the ~uadriceps (PKTQ) 
(PKTQ; 133 ± 15 vs 203 ± 23 Nm; p<0.05) and hamstring muscles (PKTH) (PKTH; 60 ± 8 vs 108 
± 16 Nm; p<0.05) and time to fatigue during a test of isometric endurance (68 ± 12 vs 100 ± 10 
sec; p<0.05) were all significantly lower in patients with CHF. 
However when corrected for the reduced lean thigh volume (muscle mass) in patients with CHF, 
PKTQ, PKTH and MVC were no longer different from control values. But the total work performed 
by the quadriceps and hamstring muscles in a 30 second isokinetic test was reduced even when 
corrected for the reduced lean thigh volume in patients with CHF. Furthermore, patients with CHF 
terminated progressive cycle exercise to exhaustion at heart rates, rates of ventilation, respiratory 
exchange ratios and blood lactate concentrations that were significantly lower than values 
achieved by control subjects during maximal dynamic exercise. These data suggest that skeletal 
muscle functional abnormalities including a decreased resistance to the development of fatigue 
exist in patients with severe CHF. 
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In the second study of this dissertation, 10 patients with CHF who participated in the first study and 
eight control subjects underwent a skeletal muscle biopsy of the vastus lateralis muscle for light 
and electron microscopic analysis. 
Significant histological and ultrastructural changes were found in all SM biopsies from patients with 
CHF. These included atrophy and hypertrophy of fibres, fibre splitting, internalized nuclei, nuclear 
knots, moth-eaten fibres, increased lipid droplets. Electron microscopy showed a large variety of 
nonspecific abnormalities, including mitochondrial changes, Z-band degeneration and 
accumulation of intracellular glycogen. Ultrastructural morphometry revealed capillary basement 
membrane width significantly increased in the SM of patients with CHF, (409 ± 13 vs 121 ± 3 nm; 
p<0.01 ). A novel, blinded, impartially scored method for grading SM pathology showed that SM 
biopsies of patients with CHF had higher scores for myopathic changes compared to C (12.0 ± 1.5 
vs 1.6 ± 1.0 arbitrary units; p<0.05). SM pathology score correlated significantly with V02 peak, 
Wlpeak, and TWQ (p<0.05 to p<0.02) but not with EF%. EF% did not correlate with either V02 
peak, Wlpeak or TWQ. 
These data support the hypothesis that: i) severe SM structural and functional abnormalities may 
limit exercise capacity in patients with CHF; ii) the severity of SM pathology but not resting systolic 
cardiac function, predicts exercise performance in patients with CHF. 
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CHAPTER 1 
LITERATURE REVIEW 
EXERCISE INTOLERANCE IN PATIENTS WITH CHRONIC HEART FAILURE 
2 
THE PHYSIOLOGICAL RESPONSE TO EXERCISE IN PATIENTS WITH HEART FAILURE 
I. Historical perspective of exercise intolerance in heart failure 
Braunwald and Grossman (1992) defined heart failure as "the condition in which abnormality of 
myocardial function is responsible for the ventricles' inability to deliver adequate quantities of blood 
to the metabolizing tissues at rest or during normal activity". The most common cause of heart 
failure is loss of cardiac muscle secondary to ischaemia on the basis of coronary artery disease. 
Viral and other cardiomyopathies are more common in younger patients. Heart failure can also 
occur in persons with poorly controlled blood pressure or with valvular heart disease. 
Of the many symptoms experienced by patients with heart failure, dyspnoea, fatigue and exercise 
intolerance are amongst the most common. Indeed, the first indication of heart failure is a 
diminished tolerance to physical exercise (Lewis 1933). Of such importance are symptoms of 
dyspnoea that functional capacity in patients with chronic heart failure was, and still is, measured in 
terms of the four-tiered classification of breathlessness (The Criteria Committee of the New York 
Heart Association Inc. 1964), which is subjective and only semi-quantitative. Only recently has 
exercise testing become more popular for the determination of functional capacity in patients with 
heart failure (Weber and Janicki 1985a; Lipkin et al. 1985). 
Historically it was believed that central cardiorespiratory factors determined submaximal and 
maximal exercise capacity in patients with chronic heart failure (Weiss and Ellis 1935, Donald et al. 
1961, Patterson et al. 1972, Bruce 1977, Clausen 1976, Reddy et al. 1988). As these patients had 
reduced cardiac output at rest and during exercise, it was thought that the her1rt was unable to 
deliver sufficient oxygen to the active skeletal muscles so that an oxygen deficiency in the active 
muscles caused fatigue. The focus of studies to determine mechanisms of fatigue at rest and 
during exercise in patients with heart failure was on pulmonary congestion, reduced lung 
compliance and dyspnoea. Even more recently, the majority of studies have continued to focus on 
the role of the heart and lungs in the limitation of exercise performance in patients with heart failure 
(Katz et al. 1989, Cowley et al. 1991 , Moore et al. 1992, Myers et al. 1992). 
However, since 1960 there has been evidence that signs and symptoms of heart failure could be 
absent even in the presence of severe heart disease (Eichna 1960). This led researchers to 
believe that central cardiovascular function may not necessarily be related to exercise capacity 
(Muller et al. 1992; Franciosa et al. 1981; Benje et al. 1980) and that chronic heart failure 
encompasses impairment of multiple organ systems (Rubin and Swan 1986) including skeletal 
muscle (Lipkin et al. 1988; Minotti et al. 1991; Buller et al. 1991; Magnusson et al. 1994). Thus, a 
reasonable clinical definition of heart failure would be: a disorder of the heart resulting in impaired 
cardiac performance leading to reduced exercise tolerance particularly on exertion, associated 
with the activation of compensatory physiological reflexes leading to salt and water retention and 
further impairment of cardiac performance (Packer 1992). 
II. Physiological factors contributing to exercise intolerance in patients with chronic heart 
failure 
3 
Although exercise intolerance is the most frequent symptom in patients with heart failure, the exact 
cause of exercise intolerance has yet to be identified. Whilst heart failure is a complex and multi-
systemic disorder, and whilst the author appreciates that central and peripheral physiological 
systems cannot be entirely separated, the limitation of exercise performance in heart failure will be 
discussed under central (cardiorespiratory) factors and peripheral (blood flow and skeletal 
muscular) abnormalities which could possibly alter exercise tolerance in patients with chronic heart 
failure 
1. Contribution of central cardiorespiratory abnormalities to exercise intolerance in patients 
with heart failure 
(i) Left Ventricular Systolic Function 
Left ventricular systolic function is compromised in chronic heart failure. It was thought that this 
would alter exercise tolerance in patients with heart failure. However, the poor relationship 
between maximal exercise capacity and indices of left ventricular (L V) function in patients with 
heart failure is now an established finding (Port et al. 1981; Baker et al. 1984; Franciosa et al. 
1981 ; Meiler 1987; Higginbotham et al. 1983; Cowley et al. 1991; Benje et al. 1980; Myers et al. 
1992; Reading et al. 1993). There is clearly no correlation between exercise capacity measured on 
a cycle ergometer or treadmill , and L V ejection fraction, nor any correlation between the degree of 
ventricular dysfunction and the clinical severity of chronic heart failure (Franciosa et al. 1979, 
1981 ). A study by Benje et al. (1980) showed that 50% of patients with an ejection fraction of less 
than 30% had normal exercise capacity. Reading et al. (1993) also reported that there was no 
relationship between resting ejection fraction and peak aerobic power or resistance in the calf 
vasculature. 
Furthermore, it was reported that patients with severe LV dysfunction increased their peak 
exercise performance after exercise training, whilst they did not show any change in L V ejection 
fraction or any reduction in wall motion abnormalities (Conn et al. 1982; Kellerman et al. 1986; , 
Hoffman et al. 1987), These findings suggest that factors other than those relating to central 
cardiovascular function may have determined the beneficial adaptations to training. Regardless of 
these findings, the ejection fraction continues to be the most common measure of central cardiac 
performance and predictor of future survival in these patients (Higginbotham et al. 1983; Cohn et 
al. 1987; Szlachic et al.1985; Swan 1986). 
(ii) Cardiac Output 
4 
Cardiac output is reduced at rest and during exercise in patients with chronic heart failure. 
Furthermore, a lower proportion of total cardiac output is delivered to skeletal muscle during 
exercise in patients with heart failure (Zelis and Flaim 1982). Bain et al. (1990) demonstrated that 
exercise time to exhaustion measured during incremental exercise in patients with heart failure, 
cannot be predicted from resting cardiac output. However, maximal cardiac output and the ability to 
increase cardiac output during exercise, do correlate with exercise capacity. Muller et al. (1992) 
showed that blood flow to the gut, kidneys, and limbs was reduced in patients with chronic heart 
failure. The lack of any correlation between limb blood flow and cardiac output helps to explain the 
lack of correlation between cardiac output and symptoms during exercise. 
Further evidence that cardiovascular function does not determine exercise capacity in patients with 
heart failure is the observation that improvement of left ventricular function by acute ingestion of 
inotropic drugs (Maskin et al. 1983), vasodilators (Wilson et al. 1984b), or repair of valvular 
stenosis (Marzo et al. 1991) does not result in an immediate normalization of exercise capacity or 
of their ventilatory response during exercise, despite marked improvements in cardiac output 
(Marzo et al. 1992; Drexler et al. 1991 a). 
(iii) Blood Pressure 
Regulation of blood pressure and temperature are major cardiovascular challenges which arise 
during muscular work and which may conflict with the need to perfuse the active muscles. Normal 
persons actively regulate mean arterial blood pressure during exercise by increasing skeletal 
muscle vascular tone when cardiac output decreases (Strandell and Shepherd 1967; Mack et al. 
1988). In patients with heart failure, this reflexly-mediated peripheral vasoconstriction is thought to 
maintain blood pressure during dynamic exercise when cardiac output has reached its maximum 
value (Sullivan et al. 1989). As a result, blood flow to the active muscles is restricted in order to 
maintain blood pressure when cardiac output is limited. 
Heart rate and mean systemic arterial blood pressure increase less during dynamic exercise in 
patients with heart failure compared to control subjects and the increase in stroke volume in the 
patients is also minimal (Wilson et al. 1984a). Despite this abnormal response, mean systemic 
blood pressure does not relate directly to exercise capacity (Higginbotham et al. 1983; Bain et al. 
1990), suggesting that exercise intolerance in these patients is influenced by factors other than 
peak systolic blood pressure (Sullivan et al. 1988b; Franciosa et al. 1984). 
(iv) Pulmonary Haemodynamics 
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It was originally thought that increased pulmonary capillary wedge pressure during exercise 
caused by left ventricular failure caused dyspnoea, which in turn limited exercise performance 
(Weber et al. 1982). However, the elevated pulmonary capillary wedge pressures at rest in 
patients with heart failure increase to the same levels during submaximal and maximal exercise 
(Szlachcic et al. 1985), and these elevated levels appear to be well-tolerated (Roubin et al. 1990). 
Massie (1988) found pulmonary capillary pressures to be no higher in patients with heart failure 
whose exercise tolerance was limited by dyspnoea compared to patients limited by leg fatigue. 
These findings indicate that mechanisms other than pulmonary capillary wedge pressure appear 
to be important in limiting exercise performance in patients with chronic heart failure (Sullivan et al. 
1988b; Franciosa et al. 1984). 
(v) Pulmonary Ventilation 
Patients with chronic heart failure have altered ventilatory responses to graded exercise. 
Hyperventilation is commonly observed during exercise in patients with heart failure and has been 
attributed to decreased lung compliance and regional ventilation-perfusion mismatch in the lungs 
as a result of the reduced cardiac output (Wada et al. 1992; Myers et al. 1991) and increased dead 
space volume (Weber et al. 1982; Sullivan et al. 1988b ). Despite this abnormal ventilatory 
response to exercise and decreased maximal ventilation (Rubin and Swan 1986), the normal 
control of ventilation by VC02 is present in patients with chronic heart failure (Sullivan et al. 1988b; 
Fink et al 1986; Myers et al. 1992). 
Although it is unclear to what extent these ventilatory abnormalities influence exercise 
performance in patients with chronic heart failure (Myers et al. 1992), it has been suggested that 
leg fatigue causes termination of exercise before there is a substantial encroachment on 
ventilatory reserve in patients with severe heart failure (Rubin and Swan 1986; Myers et al. 1992). 
It is possible that abnormal respiratory muscle function may contribute to breathlessness and 
ventilatory abnormalities in these patients (Zelis et al. 1988). Nishimura et al. (1994) reported that 
inspiratory muscle strength was impaired in patients with severe congestive heart failure and may 
limit exercise in these patients. Furthermore, 'periodic breathing' has been described in patients 
with congestive heart failure at rest and during exercise (Kremser et al. 1987; Ribiero et al. 1987). 
This has been attributed to unstable ventilatory control caused by poor circulation and to delayed 
transmission of humoral ventilatory stimuli to the chemoreceptors (Lange and Hecht 1962; 
Cherniack and Longobardo 1973). However, the exact mechanism for the periodic breathing in 
patients with heart failure is still unknown, although a central (cardiovascular) mechanism is still 
favoured (Ben Dov et al. 1992). Little is known about the time course, exact changes, causative 
factors, or the mechanisms of these ventilatory alterations. It is not known whether these 
alterations in pulmonary ventilation are the cause or effect of the exercise intolerance. 
(vi) Peak Oxygen Consumption (V02 peak) 
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Reduced V02 peak in patients with heart failure has been repeatedly confirmed (Franciosa et al. 
1979; Higginbotham et al. 1983; Weber et al. 1982; Myers et al. 1992; Miyagi et al 1993). However, 
the exact cause of this finding has not been identified. Decreased oxygen consumption in patients 
with chronic heart failure implies that either 02 supply or 02 utilization by the active skeletal 
muscle is altered. Alternatively, the muscle's capacity to exercise could be impaired even in the 
face of an adequate oxygen supply. 
Wade and Bishop (1962) suggested that the primary limitation of V02 peak in patients with heart 
failure is a relatively reduced pulmonary blood flow. However, many investigators have since 
shown that arterial oxygen tension and systemic arterial 02 saturation remains normal even at 
peak exercise in patients with chronic heart failure (Franciosa et al. 1984; Roubin et al. 1990; 
Sullivan et al. 1988b ). This suggests that pulmonary function does not limit V02 peak in these 
patients, and that peripheral alterations may indeed influence peak oxygen consumption in these 
patients. These theories are supported by the following important findings: 
(a) Weber et al. (1982) demonstrated that although peak cardiac output and peak V02 are linked, 
as the severity of heart failure worsens, the slope of the cardiac output response with increasing 
V02 decreases. This indicates that the normal relationship between cardiac output and oxygen 
consumption is altered in these patients, possibly due to increased oxygen extraction at the 
periphery from a reduced (muscle) blood flow. 
(b) Thompson et al. (197 4) and Sullivan et al. (1990) reported that femoral venous P02 does not 
decrease below the critical level of 1 OmmHg during exercise in both normal subjects and in 
patients with chronic heart failure. These findings suggest that muscle fatigue may not be caused 
by an inadequate oxygen supply to the active muscle. 
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(c) Failure to observe an improvement in oxygen uptake by skeletal muscle during exercise even 
when oxygen availability is enhanced by pharmacological intervention in patients with chronic 
heart failure (Drexler et al. 1987a,b) indicates a change in the properties of skeletal muscle itself in 
these patients. 
(d) Moore et al. (1992) reported that maximal exercise performance on a cycle ergometer was 
acutely enhanced compared to exercise with room air, when patients with heart failure inspired 
oxygen at a concentration of 50% 02. This was explained by an increased efficiency during 
exercise, so that there was a decreased ventilatory and circulatory demand at a given workload, 
while 02 delivery to muscle was maintained (Moore et al. 1992). However, this does not prove that 
oxygen supply to the active muscle was limiting during exercise. 
(e) Jondeau et al. (1992) measured V02 peak during maximal exercise with lower limbs and with 
lower limbs plus upper limbs in patients with heart failure. Patients were able to increase V02 peak 
when exercising with both lower and upper limbs. This finding was not observed in the control 
group of healthy subjects. This indicates that the exercise intolerance in cardiac patients during 
lower limb exercise was not due to a central limitation, as V02 peak increased when additional 
skeletal muscle was recruited in these patients. 
(D Recent reports indicate that V02 peak is predicted by muscle strength in patients with chronic 
disease. Isometric maximal voluntary contraction (MVC) of the quadriceps muscle correlates to 
peak V02 during exercise in patients with chronic heart failure (Lipkin et al. 1988). This finding 
indicates that skeletal muscle function can predict maximal exercise performance. Similarly, 
isokinetic quadriceps muscle strength correlates to peak V02 in patients with renal failure (Diesel 
et al. 1990). Therefore peak V02 is probably indicative of peripheral, skeletal muscular rather than 
central cardiovascular function in this group of patients (Noakes 1988; Kempeneers et al. 1989; 
Diesel et al. 1990). 
In light of the above-mentioned findings, the search for mechanisms of exercise intolerance in 
patients with heart failure has shifted from the central cardiovascular system to the peripheral 
musculoskeletal system. 
2. Contribution of peripheral abnormalities to exercise intolerance in patients with heart 
failure 
(1) Physiological alterations in the periphery during exercise in patients with chronic heart 
failure are: 
(i) Alteration of blood flow to skeletal muscle 
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Peripheral blood flow is lower during progressive dynamic and during sustained isometric exercise 
in patients with chronic heart failure compared to normal controls (Wilson et al. 1983, 1984a,b; 
Zelis et al. 197 4; Longhurst et al. 1976). A lower proportion of total cardiac output is delivered to 
exercising skeletal muscle in patients with heart failure. This occurs as a compensatory 
mechanism to prevent hypoperfusion of important non-exercising areas (brain, kidney) or to 
preserve arterial blood pressure (Sullivan et al. 1989; Zelis and Flaim 1982) or as a result of 
increased skeletal muscle vascular resistance (Zelis and Flaim 1982). Recently Yamabe et al. 
(1992) reported that blood flow to skeletal muscle (L/min/m2) during submaximal cycle exercise is 
higher in NYHA class Ill patients than to skeletal muscle of patients with less severe heart failure. 
These investigators suggest that the relatively increased skeletal muscle blood flow patients with 
severe heart failure plays a role to compensate for the insufficient cardiac output response in these 
patients. 
Many researchers have reported that systemic vascular resistance is significantly higher during 
exercise in patients with heart failure compared to control subjects (Sullivan et al. 1989; Szlachcic 
et al. 1985; Franciosa et al. 1984). But is this increased vascular resistance responsible for 
exercise intolerance in patients with chronic heart failure? Rubin and Swan (1986) suggested that 
there is a normal decrease in the vascular resistance of the vascular beds in the exercising 
muscles in proportion to the intensity of exercise in patients with heart failure. 
Impaired vasodilation during exercise is an important factor responsible for the reduced maximal 
limb blood flow in patients with heart failure (Sullivan et al. 1988b; Zelis et al. 1986; Wilson et al. 
1986; Mancini et al. 1987). But the pathophysiological cause of decreased muscle blood flow 
during exercise has not been clearly defined. Possible factors limiting blood flow to the skeletal 
muscle during exercise include alterations in vascular stiffness, in neurohumoral activation, in 
blood vessel vasodilator capacity and in flow-dependent dilation in patients with heart failure. 
These factors may play an important role in the natural history of the disease, but may not be 
critical to the impaired exercise capacity of these patients (Cohn 1992). 
(a) Alterations in vascular stiffness 
Zelis et al. (1968) studied the effects of vasodilator stimuli on peripheral resistance vessels in 
patients with congestive heart failure and found that approximately one-third of the reduced 
maximum vasodilator response during exercise can be attributed to an increased sodium content 
of the arterial wall. However, vascular resistance in the leg vessels remains increased even in 
patients receiving optimal treatment with diuretics (Le Jemtel 1986). This finding may indicate that 
other factors besides increased sodium content in the arterial wall are responsible for impaired 
vasodilation in patients with chronic heart failure. 
(b) Neurohumoral activation 
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Plasma epinephrine concentrations are elevated at rest in patients with congestive heart failure 
(Francis et al. 1984; Riley et al. 1990) and during low intensity exercise (Francis et al. 1982), but 
are not significantly different from controls during moderate and strenuous exercise (Kirlin et al. 
1986). Wilson et al. (1984b) demonstrated that at the same relative workload, plasma 
norepinephrine concentrations in patients with chronic heart failure were actually lower than in 
normal subjects, suggesting that the extent to which the sympathetic adrenergic system is 
activated during exercise may be substantially less in patients with heart failure than in normal 
subjects (Wilson et al. 1989). These findings indicate that factors other than altered plasma 
epinephrine concentrations might be responsible for the decreased blood flow to skeletal muscle in 
patients with heart failure. 
Plasma renin concentrations are elevated at rest and during exercise in patients with heart failure 
(Cody et al. 1992) and represent compensatory activation of the renin-angiotensin-aldosterone 
system (Kirlin et al. 1986). Compared to control subjects, myocardial secretion of atrial natriuretic 
factor is increased 5- to 10- fold at rest (Bates et al. 1986; Leinonen et al. 1988; Cody et al. 1986), 
and during exercise in patients with heart failure (Cody et al. 1992). Atrial natriuretic factor can 
suppress the renin-aldosterone pathway (Cody et al. 1992;86) and during exercise may minimize 
the effects of angiotensin II mediated vasoconstriction (Cody et al. 1992). 
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(c) Blood vessel vasodilator capacity 
Wilson et al. (1984b; 1985) examined the acute effects of the vasodilators dobutamine, dopamine, 
and phosphodiesterase on maximal exercise performance in patients with chronic heart failure and 
found no improvement in exercise performance even when blood flow to the legs was acutely 
increased by these agents. Nor did increased blood flow to exercising muscle induced by 
hydralazine appear to reduce femoral venous lactate concentrations, or the degree of acidosis or 
fatigue in patients with heart failure (Wilson et al. 1983). These results indicate that exercise 
performance was not dependent on muscle blood flow, as it failed to increase with an acute 
increase in muscle blood flow (Wilson et al. 1984a). 
Drexler et al. (1991 b; 1992) report that chronic administration of angiotensin converting enzyme 
(ACE) inhibitors can partially reverse mitochondrial abnormalities in patients who have depressed 
oxidative capacity of skeletal muscle during exercise. Chronic ACE inhibition not only increases 
skeletal muscle blood flow at maximal exercise (Mancini et al. 1987), but also improves functional 
capacity in these patients by acting primarily on the peripheral vasculature without changing 
intrinsic myocardial function (McGrath et al. 1985). These results suggest that there is a gradual 
reduction in structural vascular abnormalities by the chronic effect of ACE inhibition, and that this 
improves exercise performance. 
It is important to note that some patients with chronic heart failure have normal skeletal muscle 
blood flow at rest and during effort, despite markedly impaired effort tolerance (Wiener et al. 1986; 
Massie et al. 1987a). Thus impaired exercise tolerance might be related to altered skeletal muscle 
metabolism, associated with reduced muscle mass and strength, rather than altered skeletal 
muscle perfusion, at least in these patients (Mancini et al. 1988; Massie et al. 1987a). 
(d) Flow-dependent dilation 
Recent studies by Drexler et al. (1989) and Anderson & Mark (1989) indicate that flow-dependent 
dilation occurs in humans both in peripheral and coronary arteries. Endothelin, an endothelium-
derived peptide, is a circulating hormone with potent vasoconstrictor properties. Two - to threefold 
increases in circulating endothelin concentrations have been demonstrated in patients with chronic 
congestive heart failure, and concentrations increase progressively with the severity of congestive 
heart failure (Rodeheffer et al. 1992). Modulators such as endothelium-derived relaxing factor 
(EDRF) (Lerman et al. 1992), atrial natriuretic factor (ANF) (Margulies et al. 1991) and 
endothelium-derived ANF-like peptide C-type natriuetic peptide (Stingo et al 1992) have been 
proposed as therapeutic regimens to counteract the vasoconstrictor effects of endothe
lin. 
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It has been suggested that chronic high blood flow states result in endothelial changes
 that lead to 
enhanced release of EDRF (Zelis et al. 1988). EDRF mediates vasodilation, a characteristic effect 
of physical conditioning. Chronic deconditioning, accompanied by lower peripheral flow
, may 
reduce the endothelium-derived vasodilator capacity, eventually leading to a reduction
 in vessel 
diameter. Drexler and Lu (1992) found that reduced receptor-mediated endothelium-dependent 
dilation impairs exercise-induced vasodilation in skeletal muscle of rats. These result
s highlight the 
importance of the endothelium for the vascular response in both normals and in patie
nts with heart 
failure. Further research on the importance of these variables in determining blood flow
 in patients 
with heart failure and their impact on exercise tolerance and conditioning is clearly imp
ortant. 
However, the hypothesis that underperfusion of muscle contributes to exertional fatigu
e in heart 
failure remains to be fully established. 
Reduced blood flow to skeletal muscle during maximal exercise appears to be confined
 to the 
more oxidative skeletal muscle fibres. In a rat model of chronic heart failure, blood f
low to glycolytic 
(Type II) muscle fibres increased adequately with exercise while ability to increase blood flow to 
oxidative (Type I) fibres was impaired (Drexler et al. 1987a). This finding suggests that arterial 
blood flow to Type I fibres might be responsible for some of the morphological changes
 in these 
fibres in the skeletal muscle of patients with chronic heart failure, namely the Type II 
fibre 
predominance. 
(ii) Reduced blood flow causing altered skeletal muscle metabolism 
It has been suggested that reduced muscle blood flow at rest and during exercise in pa
tients with 
heart failure (Sullivan et al. 1989; Zelis et al. 1975; Massie et al. 1987a,b, 1988; Wiener et al. 1986; 
Wilson et al. 1984b; Walker et al. 1982) might be important in determining the metabolic response 
to exercise, characterized by increased glycolytic metabolism and decreased oxidative
 
phosphorylation in the skeletal muscles of patients with chronic heart failure. Howeve
r, Weiner et 
al. (1986) reported that the reduced blood flow to exercising skeletal muscle was not a consistent 
finding in forearm muscles where metabolism was altered. Massie et al. (1988) established that 
metabolic abnormalities are unrelated to blood flow by comparing the effects ischaemic
 forearm 
exercise in patients with heart failure and in normal control subjects. While the brachia! artery was 
temporarily occluded during submaximal finger flexion, patients utilized phosphocreatin
e (PCr) at a 
faster rate compared to controls despite performing much less work, and pH levels fell
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substantially. As blood flow was not different. results suggest that a functional abnormality of the 
skeletal muscle exists in patients with congestive heart failure. Buller et al. (1991) measured 
fatiguability of adductor pollicis muscle during supramaximal repetitive stimulation of the ulnar 
nerve during circulatory occlusion in patients with severe heart failure and in normal controls. The 
effect of ischaemia was greater in patients with severe (Class IV) heart failure than in patients with 
mild to moderate heart failure or in normals and the investigators attributed this to impaired skeletal 
muscle metabolism. Marie et al. (1990) confirmed this when they reported that the rate of PCr 
resynthesis in calf muscle of patients with congestive heart failure was similar following either 
aerobic or ischaemic exercise. 
(iii) Oxygen extraction and utilization 
Despite decreased blood flow during submaximal exercise, it has been demonstrated that the 
skeletal muscles of patients with chronic heart failure can compensate by increasing oxygen 
extraction, hence increasing the arterio-venous oxygen (A-V02) difference (Wilson et al. 1984a). 
However. Roubin et al. (1990) observed that although the A-V02 difference across the leg during 
exercise was greater in patients with heart failure than in normal persons, V02 peak was 40% 
lower, suggesting that the greater A-V02 difference does not compensate completely for the 
reduction in skeletal muscle blood flow. Alternatively skeletal muscle weakness may prevent 
patients with heart failure from reaching high levels of exercise at which higher V02 values would 
be measured. Wilson et al. (1984b) showed that maximal leg blood flow and maximal leg oxygen 
uptake in patients with chronic heart failure were most markedly reduced in patients with the 
poorest exercise tolerance. These findings suggest that either the skeletal muscle cannot fully 
utilize the delivered oxygen or that oxygen availability or diffusion to the skeletal muscles is 
impaired in these patients. However, these studies do not exclude the possibility that muscle 
weakness limits exercise tolerance before an oxygen limitation develops. 
(iv) Blood lactate concentrations 
It is usually argued that skeletal muscle hypoperfusion during exercise contributes to the early 
onset of skeletal muscle lactate production (Weber and Janicki 1985a,b; Wilson 1984b; Wiener et 
al. 1986; Adamopoulos & Coats 1991) and that increasing exercise intolerance is associated with 
progressively earlier increases in mixed venous blood lactate concentrations in patients with 
chronic heart failure (Wilson et al. 1984; Weber et al. 1982, Weber and Janicki 1985a). 
Furthermore, it has been demonstrated that venous blood lactate accumulation patterns correlate 
with severity of circulatory failure at rest (Meakins and Long 1927) and with severity of heart failure 
during exercise (Weber and Janicki 1985a). Increased lactate concentration is thought to be a 
contributing factor to fatigue and dyspnoea experienced during exercise in patients with chronic 
heart failure (Hanson 1994). 
(2) Skeletal muscle abnormalities 
(1) Histological and biochemical abnormalities in skeletal muscle biopsies of patients with 
chronic heart failure 
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Recent studies report that patients with heart failure identify leg fatigue as the limiting factor dur.i~g , 
exercise (Roubin et al. 1990; Kitzman et al. 1991; Myers et al. 1992) and that the stride length of 
walking is reduced in patients with chronic heart failure (Davies et al. 1992). The study of skeletal 
muscle as the possible cause of exercise intolerance in these patients has gained popular interest. 
A review of histological and biochemical findings of previous studies of skeletal muscle samples 
from patients with chronic heart failure is presented in Table 1.1. Abnormalities of skeletal muscle 
fibre morphometry, cellular organelles, capillary structure and biochemical alterations have been 
described in these patients. 
(i) Fibre morphometry 
Atrophy and hypertrophy of both Type I fibres (Lipkin et al. 1988; Sullivan et al. 1990; Poole-Wilson 
et al. 1988) and Type II fibres (Lipkin et al. 1988; Dunnigan et al. 1987; Poole-Wilson et al. 1988; 
Mancini et al. 1989; Wilson et al. 1992) have been reported in patients with CHF. The percentage 
of Type II fibres is increased in patients with CHF (Mancini et al. 1989; Sullivan et al. 1990; Drexler 
et al. 1992 ). In skeletal muscle biopsies from vastus lateralis in normal subjects, Type I muscle 
fibres constitute less than 55% of the fibres and Type II muscle fibres less than 80% (Dubowitz 
1985). Fibre predominance occurs if these figures are exceeded. 
Recent work by Lipkin et al. (1988), Mancini et al. (1991 a) and Minotti et al. (1992) suggests that 
skeletal muscle atrophy occurs early in the course of congestive heart failure and might play a role 
in the reduction of functional capacity in patients with chronic heart failure. It is thought that 
compared to normal muscle, atrophied muscle is subjected to a greater workload per remaining 
fiber when faced with a given external load and therefore develops greater reductions in PCr and 
intracellular pH (Mancini et al. 1992). Mancini et al. (1992) recently tested this hypothesis by 
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Table 1. Review of histological and biochemical findings in studies of skeletal muscle biopsies in patients with 
chronic 
heart failure. 
Structure FindinQ 
Studv 
Fibre Morehomet[i 
Type I CSA increased 
Sullivan et al. 1990. 
decreased Lipkin et al. 1988; Poole-Wilson et al. 
1988. 
Type II CSA decreased Dunnigan et al. 1987; Lipkin et al. 1988; 
Wilson et al. 1992; Poole-Wilson et al. 
increased 1988. 
Type I% decreased M
ancini et al. 1989. 
Mancini et al. 1989; Sullivan et al. 1990; 
Type II% increased Drexler e
t al. 1992. 
Mancini et al. 1989; Sullivan et al. 1990. 
Cellular organelles 
mitochondrial volume density decreased Drexler et al. 19
92. 
surface area of mitochondrial decreased Drexler et al. 19
92. 
cristae 
Subsarcolemmal mitochondrial increased Dunnigan et al. 198
7; Smith et al. 1976. 
aggregates 
interstitial cellularity increased Lipkin et al. 1988. 
Caeillaries 
capillary density normal Lipkin et al. 1988; Mancin
i et al . 1989. 
capillary density decreased Sullivan et al. 1990; Dr
exler et al. 1992. 
basement membranes thickened Lon1:1hurst et al. 1975. 
Intracellular lieid content normal Drexler et al.
 1992. 
increased Dunnigan et al. 1987; Lipkin et al. 1988, 
Smith et al. 1976. 
Intracellular glycogen content normal Drexler et al. 1992. 
decreased Sullivan et al. 1990. 
Glycolytic enzyme activity normal Mancini et al. 1989; Sulliva
n et al. 1990. 
Oxidative enzyme activity 
cytochrome oxidase decreased Drexler at al. 1992; Ralston 
et al. 1991 . 
normal Lipkin et al. 1988. 
citrate synthase decreased Mancini et al. 1989; Sullivan et al. 1990
; 
Ralston et al. 1991; Wilson et al. 1992. 
succinate dehydrogenase decreased Mancini et al. 1989; Sullivan et al. 1990
; 
Ralston et al. 1991 . 
~-hyctoxyacyl CoA decreased Mancini et al. 1989; Sullivan et al. 1990. 
dehydrogenase 
succinate cytochrome reductase normal Lipkin et al. 1988. 
Abbrev1ahons: CSA, cross sectional area. 
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correlating calf muscle volume with the metabolic response of the calf muscle to exercise during 
supine plantar flexion against increasing force. They discovered that skeletal muscle atrophy 
contributed significantly to the abnormal metabolic response to exercise, but that the correlation 
was relatively weak, suggesting that increases in muscle mass would produce only modest 
improvements in exercise capacity, and that the primary factor causing reduced pH and PCr during 
exercise is not skeletal muscle atrophy. 
A possible cause of skeletal muscle atrophy in patients with chronic heart failure is chronic 
malnutrition and deconditioning due to reduced levels of habitual activity. Carr et al. (1989) 
reported that 50% of 48 patients in severe heart failure were malnourished, defined by a decrease 
in percent body fat, a decreased weight to height index, or reduced serum albumin concentrations. 
However, they did not measure skeletal muscle volume. However, Mancini et al. (1992) showed 
that muscle atrophy was not usually associated with signs of severe malnutrition and that protein 
synthetic function was maintained in heart failure. They also reported that anorexia was not the 
sole aetiological factor for the muscle atrophy; other factors include inactivity, an increased 
catabolic state due to heightened sympathetic stimulation and increased serum concentrations of 
cortisol, ACTH, and tumor necrosis factor (Peterson et al. 1988; Levine et al. 1990; Francis et al. 
1990). 
Diaphragmatic muscle atrophy has been described in patients who are chronically ill and in 
patients with chronic obstructive lung disease who have lost weight (Arora and Rochester 1982; 
Thurlbeck 1978). Indeed, intrinsic respiratory muscle changes may occur in patients with heart 
failure and could contribute to the generation of dyspneoa during exercise, and indeed to Cheyne-
Stokes breathing. 
Gibson et al. (1987) reported that immobility in patients with heart failure is associated with a 25% 
fall in protein synthesis in quadriceps muscle. However, as skeletal muscle regains normal protein 
synthesis after heart transplantation (Morrison et al. 1988), even though patients remain relatively 
immobile after heart transplantation, immobility cannot be the sole cause of this skeletal muscle 
abnormality. 
Although atrophy may be caused by inactivity and bedrest, Poole-Wilson et al. (1988) reported that 
histological abnormalities seen in patients with chronic heart failure are not typical of the changes 
seen as a result of either prolonged bedrest or of reversible ischaemia caused by peripheral 
vascular disease. 
(ii) Cellular organelles 
Drexler et al. (1988) reported reduced number and size of mitochondria, as well as a diminished 
number of christae in the mitochondria of patients with heart failure, a finding consistent with 
diminished oxidative enzyme capacity. 
Increased subsarcolemmal mitochondrial aggregates have been reported in children with 
cardiomyopathy and chronic heart failure (Dunnigan et al. 1987). Conversely, cardiac conduction 
defects have been described in many patients with mitochondrial myopathy (Karpati et al. 1973; 
Olson et al. 1972), suggesting that the myopathy is generalized (Bussieres et al. 1993). 
(iii) Capillary abnormalities 
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Longhurst et al. (1975) studied biopsies from pronator teres muscle and found capillary basement 
membrane thickening in patients with heart failure compared to a control group. Wroblewski et al. 
(1992) documented increased capillary basement membrane thickening in the skin in patients with 
chronic heart failure and suggested that increased venous pressure due to heart failure and 
abnormal baroreceptor-mediated arteriolar vasodilation (Kassis 1989) raised capillary pressures in 
these patients. This enhanced stress could eventually lead to increased thickness of these 
basement membranes. Some studies suggest that basement membrane thickening is a result of 
repeated episodes of cell death and cell regeneration and may decrease diffusion across the 
capillary (Toussaint and Dustin 1963; Vracko 1970). However, Alpert et al. (1972) studied 
increased basement membrane thickness in diabetes and suggested that the increased thickness 
facilitates rather than retards oxygen diffusion. 
(iv) Intracellular lipid and glycogen content 
Intracellular lipid content has been reported to be normal (Drexler et al. 1992) or increased 
(Dunnigan et al. 1987, Lipkin et al. 1988). Increased intracellular lipid is a common non-specific 
finding in many muscle disorders. Intracellular glycogen concentrations may be normal (Drexler et 
al. 1992) or decreased (Sullivan et al. 1990). 
17 
(v) Glycolytic and mitochondrial enzyme activities 
Whilst the skeletal muscle glycolytic enzyme activities are not reduced in CHF (Mancini et al. 1989; 
Sullivan et al. 1990). reduced activities of the enzymes involved in aerobic metabolism (succinate 
dehydrogenase and cytochrome oxidase) is a common finding in these patients (Drexler et al. 
1991; Massie et al. 1987a,b; Mancini et al. 1988; Ralston et al. 1991 ; Wiener et al. 1986). Some 
researchers have found respiratory exchange ratios to be lower at maximal and at submaxim
al 
exercise in patients with chronic heart failure compared to controls (Myers et al. 1992; Riley et 
al.1990). The decreased values in the patients could be explained by an increased reliance on fat, 
as opposed to carbohydrate metabolism in these patients in an effort to preserve skeletal m
uscle 
glycogen stores (Costill et al. 1977). Increased fat utilization is thought to be related to elevated 
noradrenaline concentrations at rest (Francis et al. 1982, 1984; Riley et al. 1990) causing elevated 
serum free fatty acid and glycerol concentrations (Riley et al. 1990). 
An earlier fall in intracellular pH in response to submaximal and maximal exercise suggests 
accelerated rates of glycogenolysis and glycolysis (Sullivan et al. 1988c; Musch et al. 1986), 
thereby contributing to a reduced efficiency of contraction in the skeletal muscle of these patie
nts 
leading to early fatigue (Bexton et al. 1983; Norgaard et al. 1990; Poole-Wilson et al. 1988; Drexler 
et al. 1992). Furthermore, Norgaard et al. (1990) reported that reduced Na/K pump activity in 
skeletal muscle in patients with chronic heart failure leads to a decreased sodium gradient ac
ross 
the cell membrane, causing intracellular accumulation of calcium and hydrogen. The comprom
ised 
function of the mitochondria by altered handling of calcium ions within the cell may result in 
increased levels of ADP and Pi at any given workload during exercise (Dawson et al. 1978; 
Karlsson and Saltin 1970; Harmansen 1981 ). Thus, the onset of fatigue in these patients could be 
a consequence of ATP supply not being able to meet demand in the active muscles during 
exercise. Qualitative changes in skeletal muscle, such as an altered myosin isoform expression, 
may also change the skeletal muscle contractile function in these patients (Sullivan et al. 1990b). 
(vi) Relation of abnormal skeletal muscle histology to the impaired exercise tolerance in 
CHF. 
The studies reviewed above have documented changes in the skeletal muscles in CHF mainl
y on 
light microscopic analysis. Few studies have yet provided a detailed description of the 
ultrastructural findings. Although Drexler et al. (1992) reported a relationship between 
mitochondrial volume density and peak oxygen consumption in patients with CHF, the relation
ship 
of skeletal muscle histological abnormalities to the impaired exercise tolerance of these patients 
has not been more fully defined. 
(vii) Phosphocreatine recovery time 
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Mancini et al. (1992) reported that PCr recovery time after exercise, rather than muscle volume, 
correlated with the Pi-to-PCr and pH response during exercise in these patients, emphasizing that 
abnormal muscle metabolism, rather than atrophy per se, is probably the dominant mechanism for 
reduced exercise tolerance in patients with heart failure. 
(2) Oxidative enzyme activity 
Reduced oxidative capacity of skeletal muscle enzymes involved in aerobic metabolism, including 
succinate dehydrogenase and cytochrome oxidase, is a common finding in patients with heart 
failure (Drexler et al. 1991 ; Wilson et al. 1983, 1984; Massie et al. 1987a,b; Mancini et al. 1988; 
Ralston et al. 1991 ; Yancy et al. 1989; Wiener et al. 1986). Drexler et al. (1988) reported a close 
relationship between the oxidative capacity of skeletal muscle and V02 peak during exercise in 
patients with chronic heart failure, and suggested that the extent of alteration of skeletal muscle 
metabolism was related to exercise capacity in these patients. Furthermore, Stratton et al. (1994) 
reported that training improved oxidative capacity of forearm skeletal muscle, indicating that the 
impaired oxidative capacity may be due to inactivity and responds to a period of training. However, 
Lipkin et al. (1988) reported that skeletal muscle oxidative enzyme activity was within the normal 
range in patients with severe chronic heart failure. This finding is supported by Minotti et al. 
(1991 b; 1993), who reported that since oxygen extraction by skeletal muscle is near complete in 
these patients, skeletal muscle metabolic disorders are not likely to substantially limit maximal 
exercise performance. 
(3) Increased blood concentrations of tumor necrosis factor 
Increased circulating concentrations of tumor necrosis factor (TNF) in skeletal muscle of patients 
with heart failure have been measured. However, this cytokine is not present in all patients with 
cardiac abnormalities (McMurray et al. 1991 ; Levine et al. 1990). Furthermore, Drexler et al. 
(1991 b) recently reported that circulating concentrations of tumor necrosis factor do not correlate 
with the extent of skeletal muscle damage. 
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In summary, few studies have studied skeletal muscle abnormalities and whilst some studies have 
documented gross ultrastructural changes in the skeletal muscles of patients with chronic heart 
failure (Lipkin et al. 1988; Drexler et al. 1992), few studies have yet provided a detailed description 
of these changes or have provided adequate control groups to establish the specificity of these 
changes to heart failure. 
Ill. Skeletal muscle function in patients with chronic heart failure 
(1) Isometric skeletal muscle function 
Several studies have reported that skeletal muscle function is impaired in patients with heart 
failure, even when the heart failure is mild (Lipkin et al. 1988; Minotti et al. 1991 a; Buller et al. 
1991 ). Lipkin et al. (1988) documented that isometric maximal voluntary contraction of quadriceps 
muscles of heart failure patients was 55% of the predicted strength for an age-, mass- and sex-
matched population even after taking into account the decrease in cross-sectional area of the 
muscle, but no control group was actually tested. 
Muscle cross-sectional area in healthy subjects is directly related to force development (Schantz et 
al. 1983; Maughan 1984) and it has been assumed that decreased cross-sectional area of skeletal 
muscle causes decreased skeletal muscle strength in patients with heart failure (Magnusson et al. 
1994). 
Buller et al. (1991) reported that supramaximal repetitive stimulation of a large muscle mass 
(quadriceps) caused rapid onset of fatigue and reduced isometric force production in patients with 
severe heart failure compared to patients with mild heart failure and controls, whereas force 
production and fatigue of adductor pollicis was not different between groups. However, the 
maximal isometric force production per unit muscle cross-sectional area was within the normal 
range (according to norms of Chapman et al. 1984). This led to the conclusion that the reduction in 
force for the larger muscle mass was not due to impaired force production by the myofibril. Minotti 
et al. (1991 b) reported that maximal voluntary contraction was not different in patients compared to 
control subjects even though maximal cross-sectional area of the knee extensors was significantly 
smaller in the patients. They also found a strong correlation between isometric strength and 
maximal cross-sectional area of the thigh muscles. In addition, Magnusson et al. (1994) found that 
although the isometric strength of the quadriceps femoris muscle of these patients was 14% less 
than age-matched controls, the tension per unit of muscle cross-sectional area was simHar 
between groups, which is in accordance with the report of Buller et al. (1991 ). 
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(2) lsokinetic skeletal muscle function 
Minotti et al. (1991 b) measured peak torque and endurance during isokinetic knee extensions in 
these patients and found that dynamic muscle endurance was significantly lower in patients 
compared to controls. Furthermore there was only a weak correlation between dynamic endurance 
and knee extensor cross-sectional area in these patients (Minotti et al. 1993). Also, Magnusson et 
al. (1994) reported a markedly lower dynamic endurance capacity of the quadriceps femoris 
muscles in patients with chronic congestive heart failure compared to age-matched controls, but 
there was no difference in peak tension per unit of cross-sectional area of the skeletal muscle. 
Thus it appears that diminished skeletal muscle endurance capacity during repetitive exercise is 
the most consistent finding in these patients, and that a reduction in muscle strength is not always 
a consistent finding, especially when the cross sectional muscle area is taken into account (Minotti 
et al. 1991 b, 1993; Buller et al. 1991 ). 
(3) Skeletal muscle recruitment 
It has been suggested that central nervous system inhibition of skeletal muscle afferents may limit 
exercise during hypoxia or hypoperfusion in normal subjects (Hochachka and Dunn 1983; Green 
1990; Garner et al. 1990). It is not known whether this is due to a feedforward or feedback 
mechanism from damaged or hypoxic skeletal muscle, or whether this mechanism could affect 
exercise tolerance in patients with chronic heart failure. 
Minotti et al. (1992) measured amplitude and area of the M wave (compound muscle action 
potential) decline during progressive, fatiguing exercise in an attempt to determine whether the 
accelerated fatigue in these patients is due to impaired muscle activation as a result of inadequate 
central motor drive or neuromuscular transmission, or by a change in muscle itself. Their findings 
indicate that the more rapid onset of muscle fatigue in patients with congestive heart failure is not 
caused by impaired central motor drive or neuromuscular junction transmission. Rather, they 
suggest that this fatigue is caused by an abnormality in the muscle itself. 
IV. Additional factors and their possible effect on exercise performance in patients with 
chronic heart failure 
It is possible that the medication ingested by patients with chronic heart failure, chronic 
deconditioning due to heart failure, or the age of the patient might also contribute to the impaired 
exercise performance of these patients. 
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(1) Effects of medication on exercise performance in patients with heart failure 
Ingestion of medication plays a key role in the management of symptoms in patients with chron
ic 
heart failure and the effect of these agents on exercise performance requires consideration. A
 
recent significant development in medical management of heart failure is the introduction of 
angiotensin converting enzyme (ACE) inhibitors. Chronic ingestion of either captopril and enalapril 
not only improves signs and symptoms of heart failure and increase exercise performance, bu
t 
reduces mortality in patients with chronic heart failure (SOL VD Investigators 1992; Pfeffer et al. 
1992). 
The negative inotropic effect of beta blockers causes haemodynamic and clinical deterioration
 in 
patients with heart failure (Kupper 1991 ), and may also cause an increased rate of perceived 
exertion during submaximal exercise effecting either the central nervous system or skeletal mu
scle 
in these patients (Derman et al. 1991 ). Diuretics are effective in reducing total body sodium and 
water content, and thus relieving the symptoms due to fluid retention in patients with heart failu
re, 
but there are no data to suggest that they improve quality of life or exercise tolerance in these 
patients. Digitalis does appear to be effective in improving prognosis in patients with heart failu
re 
(Packer 1992), but the benefits are confined to those patients who have markedly dilated left 
ventricles, with markedly impaired systolic function. 
(2) Physical deconditioning 
Patients with heart failure are less active than normal healthy controls. The pattern of skeleta
l 
muscle changes seen in patients with chronic heart failure is consistent with the effects of chro
nic 
exercise deconditioning, but the magnitude of these changes exceeds those which occur after
 
exercise deconditioning in normal subjects (Coyle et al. 1984). In both states there is exercise 
intolerance, sympathetic activation, increased resting heart rate, reduced heart rate variability, 
atrophied skeletal muscle and reduced activity of skeletal muscle oxidative enzymes 
(Adamopoulos & Coats 1991; Saltin et al. 1988; Sullivan et al. 1986; Drexler et al. 1987b). 
Deconditioning appears to be one factor involved in the development of these potentially rever
sible 
skeletal muscle alterations (Drexler et al. 1992) and for the impaired peripheral vasodilation during 
exercise in patients with chronic heart failure (Sinoway et al. 1988). 
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(3) Contribution of age to exercise intolerance in patients with heart failure 
As various physiological changes occur with increasing age, it is important that these changes
 are 
considered when the physiological response to exercise in patients with heart failure is gauged
. 
Although it has been reported that oxygen consumption, cardiac output, stroke volume, ejection 
fraction, heart rate and Frank-Starling response at maximal exercise are significantly reduced 
in 
normal elderly subjects compared to younger subjects (Kitzman et al. 1989), the muscle strength 
of patients with chronic heart failure (Buller et al. 1991) is significantly less than age-matched, 
sedentary controls (Minotti et al. 1991 a). Hence, while cardiovascular function is attenuated in both 
elderly persons and elderly persons with chronic heart failure, skeletal muscle strength appear
s to 
be affected to a greater extent in patients with chronic heart failure than in age-matched seden
tary 
controls. 
V. Effects of exercise training on exercise performance in patients with heart failure. 
The effects of exercise training in patients with heart failure have previously been reviewed. 
Briefly, exercise training programmes are of benefit in improving exercise tolerance and sympt
oms 
of patients with moderate to severe heart failure secondary to ischaemic heart disease (Conn et al. 
1982; Sylvan et al. 1988; Kellerman et al. 1988). Minotti et al. (1990) showed that regular exercise 
training improved the endurance and metabolism of trained muscle but had no effect on untrain
ed 
forearm muscles. Other adaptations to exercise training which may occur are: decreased 
adrenergic activity during exercise (Coats et al. 1990), changes in substrate delivery, and 
alterations in intramuscular blood flow distribution (Arnolda et al. 1990). Increased exercise 
performance in these patients is associated with improvements in oxygen uptake by the exerc
ising 
muscle (Sullivan et al. 1988a; Coats et al. 1990). 
Recently Stratton et al. (1994) reported a 65% increase in endurance exercise capacity, reduced 
rates of intracellular acidification and PCr utilization during exercise, and an increased maxima
l 
rate of mitochondrial ATP synthesis after one month of forearm isotonic and isometric exerc
ise 
training in patients with heart failure. 
VI. Overall summary and aim of this thesis 
According to this literature review, heart failure is probably more appropriately defined as a clin
ical 
condition in which a chronic cardiac abnormality results in effort intolerance and eventually 
a series 
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of neurohumoral adaptations (Packer 1988). Previously, central cardiorespiratory factors were the . 
main focus of researchers, who measured mainly central physiological variables during exercise to 
determine the limitation of exercise in these patients. However, more recently exercise intolerance 
in patients with CHF has been explained by abnormalities in peripheral blood flow and in skeletal 
muscle metabolism 
The many inconsistencies discussed in the review indicate that other factors could be responsible 
for exercise intolerance in these patients. It is probable that whilst both central and peripheral 
factors contribute to the exercise intolerance in these patients, patients may be limited more by 
disease of skeletal muscle than by dyspnoea or central fatigue. However, few studies have 
examined the role of skeletal muscle in the limitation of exercise performance in patients with 
chronic heart failure. 
Therefore the first aim of Chapter 3 is to measure both isometric and isokinetic peak skeletal 
muscle function, as well as tests of skeletal muscle function during repeated skeletal muscle 
contractions and time to the onset of fatigue and isokinetic total work of the lower limb muscles. In 
addition. few studies have measured physiological variables when patients and controls have 
started at low identical workloads. Thus Chapter 3 also describes the physiological response 
during graded exercise to exhaustion in patients with severe CHF and normal controls using 
identical exercise test protocols. 
Some recent studies have documented gross changes in the histology of the skeletal muscles in 
patients with CHF but it is not known if the severity of the histological abnormalities of the skeletal 
muscles in patients with CHF relates to the exercise intolerance experienced by these patients. 
Furthermore, no studies have provided control groups, few studies have examined the 
ultrastructure of the skeletal muscle in patients with CHF, and a method for quantification of 
skeletal muscle structural damage does not exist. Thus the aim of Chapter 4 was to focus on the 
structural changes of the skeletal muscle in patients with severe chronic heart failure and to 
describe the histological and ultrastructural findings in skeletal muscle biopsy samples from 
patients with CHF, to develop a simple histological grading system to quantify the magnitude of 
these changes. and to determine the relationship of these changes to alterations in the exercise 
capacity of these patients. The conclusions from these studies are detailed in Chapter 5. 
Chapter 2 describes the methodology used in this thesis, whilst Chapter 6 lists the references for 
this thesis. Further research of the peripheral alterations and abnormalities of skeletal muscle 
structure and function in these patients is warranted. 
CHAPTER 2 
GENERAL METHODOLOGY 
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MATERIALS AND METHODS: 
The general methodology for chapters 3 and 4 are described in this chapter. 
(1) General considerations 
To be included in the studies. patients had to be free of any serious respiratory or musculo-s
keletal 
disorders. In addition, the control subjects had to be free of any underlying cardiovascular disease. 
Subjects and controls were instructed to avoid any strenuous physical exercise for 36 hours 
preceding each laboratory test. No caffeine containing food or drinks were to be consumed oil
 the 
day of testing. All tests were performed at the same time of day, approximately two to three ho
urs 
after ingestion of the last medication dose. The study protocols were approved by the Ethics a
nd 
Research Committee of the F acuity of Medicine at the University of Cape Town. All subjects 
provided written informed consent and were given a full medical examination and resting 
electrocardiogram before the study commenced. 
(2) Anthropometrical analysis of body composition 
Body composition was assessed using an anthropometric technique which fractionated the bo
dy 
composition into muscle mass (Martin et al. 1990) and fat and lean body mass (Durnin and 
Womersley 197 4). Chest measurements and relaxed and contracted arm girth measurements 
were also recorded. Somatotype was calculated according to the procedure of Heath and Car
ter 
(1967). Standing height without shoes was measured to the nearest 0.1 cm. Skinfold thickness 
was measured to the closest 0.1 mm at triceps, biceps, suprailliac and subscapula sites on t
he 
right side of the body with Holtain skinfold calipers. Density was estimated from the sum of the
 four 
skinfold thicknesses, using the equations of Durnin and Womersley (197 4). Percent fat was 
calculated from density values using the Siri formula. 
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(3) Blood pressure and heart rate measurement at rest and during exercise 
After subjects remained seated in a quiet environment for a period of fifteen minutes, the resting 
heart rate and blood pressure (Korotkoff Phase I and IV) was measured and recorded. Blood 
pressure at rest and every two minutes during exercise was measured by means of audible 
sphygmomanometry using a calibrated mercury column sphygmomanometer with an appropriately 
sized cuff. The cuff was placed on the arm that did not have an intravenous cannula. The 
measurement of diastolic blood pressure during exercise is sometimes difficult. However, if Phase 
IV of the Korotkoff sounds is taken, the results are quite reproducible. Heart rate was determined at 
rest and each minute during exercise, using a Loheimer M607 monitor (Munich, Germany) using 
self-adhering electrodes placed in the CM5 position. 
(4) Graded exercise tests to exhaustion 
Both patients and control subjects performed maximal progressive exercise to exhaustion on an 
electro-mechanically braked cycle ergometer (Godart, Bilthoven, Holland). Prior to testing the 
height of the saddle was adjusted to the preferred height for the patient. During exercise, subjects 
cycled with a model no. 2766 counterbalanced head support holding a model no. 2700 Rudolph 
valve (both by Hans Rudolph Inc., Kansas City, KA). A nasal clip prevented nasal breathing. 
Subjects commenced pedaling at a workload of 5 watts (W) for the first three minutes. The 
workload was increased by 10 W/min until the subject voluntarily terminated the test. During 
exercise expired air was analyzed for 02 (Ametec 02 Analyzer Model 3A, Theridox, Pittsburg, 
USA) and CO2 content (Ametec Carbon Dioxide Analyzer Model CD-3A, Theridox, Pittsburg, USA). 
Both analyzers were calibrated before and after each test using gases of known composition. 
lnspiratory volume was recorded with a Mijnhardt dry gas meter which had been calibrated against 
a Collins chain-compensated gasometer (Collins Inc., Braintree, Massachusetts, USA). 
The V02 max was taken as the highest rate of oxygen consumption measured during any 60 
seconds (Noakes 1988). Rates of oxygen consumption (V02), carbon dioxide production (VC02), 
respiratory exchange ratio (RER) and ventilation (Vi) were calculated every 3 seconds by an on-
line micro computer (Sperry, ·salt Lake City, Utah, USA) using software (ART) based on 
conventional equations as previously described from this laboratory (Noakes et al. 1990). The 
average value for each minute for each parameter was stored for later printing. 
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Peak workload was taken as the highest workload maintained for a complete minute during the 
test. When a subject was unable to complete the full minute at a particular workload, the workload 
of the immediately preceding, completed workload was recorded as the peak workload. The same 
method also was used to calculate the exercise time to exhaustion. 
Patients and control subjects were asked to report their level of perceived exertion from the 
appropriate scale after each minute of the exercise test. Most studies have used the 20-point Borg 
scale. This method caused inaccurate scaling of variables such as blood lactate concentrations 
and ventilation, which increase according to non-linear power functions (Noble et al. 1982). 
Consequently we have used the 10-point category scale with ratio properties (Borg 1980, 1982). 
The ratio scale has verbal expressions which are simple to understand and more accurately 
describe sensations of perceived peripheral effort. 
,. Indications or halting the exercise test before voluntary exhaustion were: 
(a) Adverse symptoms; for example, severe dyspnea, light headedness, confusion and severe 
fatigue 
(b) Adverse signs; for example, facial pallor, drop in heart rate or blood pressure, or failure of blood 
pressure to rise with increasing effort, systolic blood pressure exceeding 280 mmHg, or diastolic 
blood pressure exceeding 140 mmHg. 
(5) Collection of blood for analysis of blood lactate concentration during graded exercise to 
exhaustion / 
Prior to the start of the cycle test, an 18-guage flexible catheter (Criticon, Tampa, Florida, USA) 
was inserted into a subcutaneous forearm vein of each subject. A 3-way stopcock (Discofix-3, 
Belgium) was attached for multiple blood sampling and kept patent by means of a saline drip 
(Sabax sodium chloride 0.9% / Plexitron AFC0197, Johannesburg, South Africa). In cases where 
blood sampling was difficult, a blood pressure cuff was applied to increase distal venous pressure. 
Before blood samples were collected, 2.0 mis of blood were drawn to remove any saline that may 
have been present in the catheter. Blood sampling took place in the rested state before exercise 
began, and subsequently at one-minute intervals during the exercise bout. A further blood sample 
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was drawn at exhaustion and again each minute for 5 minutes into the post-exercise recovery 
period. On completion, the samples were spun in a Sigma 302-K centrifuge (Munich, Germany) at 
2700 RPM for 12 minutes. Thereafter, the plasma was removed and frozen until later analysis for 
lactate concentration. 
(6) Analysis of blood lactate concentrations 
This method was adapted from Gutman and Wahlefeld (1974). Plastic Greiner test-tubes 
containing 2 ml of 0.6 N perchloric acid (PCA) were weighed on a Sartorius 1412 scale (Gottingen, 
West Germany) and the weights were recorded. These tubes were kept in a refrigerator until the 
samples were ready to be collected, at which time the tubes were then kept cold on ice. 
Approximately 1 ml of whole blood sample was added to the tube containing the PCA, and inverted 
vigorously to mix. The samples were kept on ice until completion of the exercise test, and then 
centrifuged at 40c for 15 minutes at 2000 rpm. They were then re-weighed to calculate the actual 
volume of blood added. The supernatant was then decanted into labeled Eppendorf test-tubes, and 
stored at -2ooc until the assay was performed. 
Assay method: Glass test-tubes were labeled as follows; 3 x blanks, 2 x standards, and then 
sample tubes in duplicate. Reagents were added to each of the tubes as follows: 
Standard (ml) Blank (ml) Sample tube (ml) 
Hydrazine buffer 1 1 1 
NAD 0.1 0.1 0.1 
PAC 0.1 
LDH 0.1 0.1 0.1 
Supernatant 0.1 
Standard 0.1 
The hydrazine/ glycine buffer was 0.4M hydrazine and 0.5M glycine in distilled H20, adjusted to pH 
9.0. The NAO solution (± 30mM) was prepared by dissolving 100 mg NAO in 5 ml distilled H20, 
and then stored at -20°C until needed. The LOH suspension (± 5 mg protein/ml) was stored at 40c 
and used undiluted. A dilution of 1.0M lactate standard was used. 
The standard, blank and test solutions were separately mixed on a vortex mixer. These solutions 
were covered with parafilm, and then placed in an incubator to react for 30 minutes at 370c. 
Optical density changes were recorded with a Beckman OU-62 spectrophotometer (Beckman 
Instruments Inc., England) previously zeroed at 340 nm against distilled H20. The following 
calculation was used to determine the lactate concentration of the samples : 
Lactate cone. (mmol/1) = AB x 1.945 x (2 + vol blood) 
vol blood 
(Where AB= sample absorbance - blank absorbance) 
(7) Skeletal muscle biopsy procedure 
Ten minutes after the patient had completed the graded exercise test, a sample of muscle was 
removed from the vastus lateralis under local anaesthesia according to the needle biopsy 
technique of Bergstrom et al. (1962), as modified by Evans et al. (1982). 
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The muscle was divided into two pieces: One piece of the muscle was snap-frozen in isopentane 
and cooled in liquid nitrogen. Transverse sections (5-7 pm) were stained for haemotoxylin and 
eosin, Gomoris trichrome, P- nicatinamide adenine dinucleotide reduced (NADH), Oil Red O and 
adenosine triphosphate (ATPase) at pH 4.3, 4.6, and 9.4. The fibre type proportions and the 
minimum diameter of approximately 150 Type I and Type II muscle fibres differentiated by ATPase 
staining were measured using an IBAS Kontron image analysis system. 
The second portion of the muscle was desensitized in 3% phosphate buffered glutaraldehyde for 
10 mins. The tissue was sliced into smaller sections and fixed overnight. The slivers of transverse 
and longitudinal muscle sections were post-fixed in 1 % buffered osmium tetroxide (pH 7.4) and 
processed by standard methods into Spurrs epoxy resin. Ultra-thin transverse and longitudinal 
sections were stained with uranyl acetate and lead citrate and examined using a Phillips 201 
electron microscope. 
Ultrastructural morphometric measurements of the capillary basement membranes were 
performed using the technique of Spierstein et al. (1968) and an IBAS Kontron Image analysis 
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system. Only transverse capillaries were selected for analysis. A plastic sheet with 20 radiating 
lines exactly 18 degrees apart, was placed centrally on the capillary. Measurements were made at 
the points where the lines intersected the basement membrane. Measurements were not taken 
when the radiating lines intersected a pericyte. If at least 10 measurements could not be obtained 
from a single capillary, it was discarded. 
(8) Tests of skeletal muscle function 
(i) Isometric muscle function 
Maximum isometric voluntary strength of the right quadriceps muscle was measured on a custom-
made, leg stabilizing chair and load cell built according to the specifications of Edwards et al. 
(1977). In that chair, the patient sat with his or her arms folded, back angled at goo, knees at goo 
flexion and pelvis secured to the chair by an adjustable belt. Once the use of the hip flexors had 
been limited by securing the pelvis, a cuff was placed above the malleoli of the right ankle and 
linked via a chain to a pre-calibrated strain gauge for the measurement of torque during contraction 
of the knee extensors. The lever length, used to calculate torque, was the distance between the 
attachment of the chain to the cuff and the lateral epicondyle of the knee. 
Outputs from the strain gauge were processed by a locally built Data Acquisition Unit (Scientific 
Exercise Systems, Cape Town) interfaced with an IBM-compatible personal computer, which 
displayed the results on the computer screen. Patients first performed three 4 sec maximum 
voluntary contractions (MVCs) for the measurement of peak isometric torque. Sixty seconds after 
completion of this test the subject was encouraged to generate a MVC for six seconds followed by 
a four second rest period. Throughout this test. the patients were encouraged verbally to produce 
maximal contractions and to repeat the cycle as frequently as possible. This cycle was repeated 
until the subject was unable to generate a torque of 70% of their initial MVC. The time to reach this 
point was recorded as the time to fatigue, and is a measure of resistance of the skeletal muscle to 
the development off atigue (Bigland-Richie et al. 1986). 
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(ii) lsokinetic muscle function 
lsokinetic muscle strength was measured with a Cybex lsokinetic Dynamometer (Cybex II 
lsokinetic Dynamometer; Cybex, Ronkonkoma, NY) with a Cybex Data Reduction computer. This 
system is designed to maintain angular velocity, constant at a pre-set level regardless of the torque 
generated by the subject. The subjects were seated on the Cybex apparatus with the head of the 
femur fully supported and the knee flexed to goo. The lever arm was secured to the subject via a 
shin pad placed just proximal to the malleoli. In order to isolate movement to the knee joint, thigh 
and shin pad straps were fastened as tight as were tolerable for the patient. During the testing, 
subjects were instructed to keep their arms folded across their chests. The fulcrum of the lever was 
positioned in line with the axis of rotation which corresponds to the transverse line through the 
femoral condyles. Each patient was given a practice bout at each testing speed. This warm-up 
consisted of 5 familiarization repetitions at 600/sec and at 1800/sec. After the familiarization period, 
patients rested for 2 minutes before starting the test. Any necessary adjustments to the equipment 
were made during this time. The strength test measured maximum isokinetic torque of the 
quadriceps and the hamstring muscle groups of the dominant limb, recorded during 3 maximal 
contractions through a full range of motion at a limb contraction speed of 600/sec. An endurance 
test of the dominant leg was then performed. After a 5 minute rest, the subject performed repeated 
full knee extensions for 25 seconds at a rate of 1800/sec. Total work and power generated by the 
quadriceps and hamstrings as well as the peak acceleration energy during the first 0.125 seconds 
of torque production at this speed were recorded. Verbal encouragement was given throughout the 
tests. 
CHAPTER 3 
EXERCISE TOLERANCE AND SKELETAL MUSCLE FUNCTION IN PATIENTS WITH CHRONIC 
HEART FAILURE 
Introduction 
As described in Chapter 1, fatigue and exercise intolerance are amongst the most common 
symptoms experienced by patients with CHF. 
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Abnormalities in peripheral blood flow (Zelis et al. 1974; Zelis and Flaim 1982; Le Jemtel et al. 
1986; Sullivan et al. 1989) and in skeletal muscle metabolism (Wiener et al. 1986; Massie et al. 
1987a, b; Sullivan et al. 1990, 1991 ; Drexler et al. 1988, 1992; Mancini et al. 1992; 1994) are 
present in patients with CHF and could contribute to their impaired exercise tolerance. The 
metabolic abnormalities and the impaired exercise tolerance may be present even without 
alteration in limb blood flow (Wiener et al. 1986; Massie et al. 1988) and may be partially reversed 
by exercise training (Stratton et al. 1994). It is therefore important to study the skeletal muscle 
itself to gain understanding of exercise intolerance in patients with CHF. 
Historically, it has been argued that pulmonary congestion due to left heart failure and reduced 
lung compliance cause dyspnoea that limits the exercise tolerance of such patients. Thus central 
cardiorespiratory factors were the main focus of researchers, who measured mainly central 
physiological variables during exercise to determine the limitation of exercise in these patients 
(Clausen 1976, Bruce et al. 1977, Reddy et al. 1988, Cowley et al. 1991, Kitzman et al. 1991, 
Myers et al. 1992). 
Recent studies however, have indicated that exercise capacity in patients with CHF may not be 
limited solely by central cardiorespiratory factors (Franciosa et al. 1981, 1984; Sullivan et al. 1989; 
Roubin et al. 1990; Minotti et al. 1992; Jondeau et al. 1992). Rather, the focus of more recent 
studies has shifted to aspects of the peripheral circulation and skeletal muscle as possible factors 
limiting the exercise tolerance of patients with CHF. 
However, only few studies have measured skeletal muscle function during exercise (Lipkin et al. 
1988; Minotti et al. 1991; Buller et al. 1991 ; Magnusson et al. 1994) and some have drawn 
conclusions from tests of single maximal skeletal muscle contractions. 
Therefore the first aim of this study was to measure both isometric and isokinetic peak skeletal 
muscle function, as well as tests of skeletal muscle function during repeated skeletal muscle 
contractions and time to the onset of fatigue of the lower limb muscles. 
Most studies of graded exercise to exhaustion in patients with CHF have examined physiological 
variables during exercise in both patients with CHF and normal controls. However, both patients 
and controls initiate exercise at different workrates, and conclusions about comparative exercise 
physiology are drawn from measurements at relative percentages of the V02 max (Colucci et al. 
1989, Riley et al. 1990). Few studies however have measured physiological variables when 
patients and controls have started at low identical workloads.Thus the second aim of this study 
was to describe the physiological response during graded exercise to exhaustion in patients with 
severe CHF and normal controls using identical exercise protocols. 
Methodology 
Subjects characteristics on entry to the study 
Table 3.1 Details the characteristics of the patients with CHF on entry to the study. 
~ Table 3.1 Characteristics of patients with CHF 
Duration of heart Cause of cardiac Resting 
Patient Sex Age (yr) Mass (kg) failure (months) failure EF% Hb (g%) 
1 M 60 71 12 lschaemic CMO 12 13.3 
2 M 42 63 3 Post Viral CMO 18 14.0 
3 M 40 68 12 Idiopathic CMO 12 14.6 
4 M 46 65 6 lschaemic CMO 12 14.2 
5 M 47 69 9 lschaemic CMO 15 12.7 
6 M 52 85 6 Idiopathic CMO 18 15.5 
7 M 55 97 15 lschaemic CMO 20 12.6 
8 M 45 120 12 Idiopathic CMO 26 13.1 
9 M 59 80 20 Idiopathic CMO 13 11 .2 
10 M 34 106 24 / lschaemic CMO 30 14.1 
11 M 36 113 24 lschaemic CMO 14 13.6 
Mean 47 85 13 17 13.5 
SEM 3 6 2 2 0.3 
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Abbreviations: M, male; m, metres; kg, kilogram ; CMO, cardiomyopathy; EF, ejection fraction; Hb, haemoglobin; SEM, standard error of the mean. 
Eleven male patients mean(± SEM) age 47 ± 3 yr (range 34-60 yr), mean mass 85.0 ± 6.0 kg 
(range 63-120 kg) with CHF (NYHA Class Ill-IV) who were awaiting heart transplantation were 
recruited froin the Departments of Cardio-Thoracic Surgery and Cardiology at Groote Schuur 
Hospital, Cape Town, South Africa. Selection of the patients for cardiac transplantation was by 
internationally accepted criteria (Mudge et al. 1993). Four patients had CHF due to idiopathic 
' 
cardiomyopathy, six due to ischaemic cardiomyopathy, and one due to viral myocarditis. Mean 
ejection fraction of the CHF group prior to cardiac transplantation was 17 ± 2 % (range 12-30%). 
No patients had exercised regularly for at least 2 yr before commencement of the study. Patients 
were excluded from this study if they had signs, symptoms or a history of any other chronic 
disease, or if they were bedridden or unable to exercise. Data for isometric skeletal muscle 
function was not obtained from one patient who underwent heart transplantation before skeletal 
muscle function testing could be performed. Equipment malfunction interrupted respiratory gas 
testing in two control subjects. Blood lactate was not measured in one control subject. 
Medications 
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Patients receiving medications at the start of the trial were instructed to continue with their 
medication during the period of exercise testing. Medications used by these patients are described 
in Table 3.2. 
Table 3.2. List of medications ingested by patients with CHF 
Pt No. Medication 
1. Captopril; digoxin; furosemide; glibenclamide; isosorbide dinitrate; aspirin 
2. Berotec; euphyllin; furosemide; digoxin; warfarin 
3. Captopril ; furosemide; digoxin; potassium supplementation 
4. Captopril; digoxin; metolazone; warfarin; potassium supplementation 
5. Captopril ; digoxin; furosemide; spironolactone; metolazone; warfarin; potassium supplementation 
6. Digoxin; furosemide; allopurinol; voltaren; colchicine; warfarin; potassium supplementation 
7. Captopril ; furosemide; allopurinol; zaroxyllin; warfarin; potassium supplementation 
8. Captopril ; furosemide; digoxin; disprin; warfarin 
9. Captopril; digoxin; furosemide; isosorbide dinitrate; warfarin; magnesium and potassium supplementation 
10. Enalapril ; digoxin; furosemide; potassium supplementation 
11 . Captopril; diltiazem; digoxin; furosemide; ranitidine; alprazolam; potassium supplementation 
All patients were receiving four or more medications. Categories of medications included diuretics, 
angiotensin converting enzyme inhibitors, digitalis, anticoagulants, allopurinol and potassium 
supplementation. Two patients were ingesting nitrates and one patient was ingesting oral anti-
diabetic agents. 
Exercise tests performed on these patients were compared to data from ten sedentary age- and 
mass- matched individuals who were free of any chronic disease. Mean age of this group was 39 ± 
3 yr (range 26-56 yr), and average mass was 85.8 ± 5.3 kg (range 63-118 kg). These values were 
not significantly different from the patient group. 
Exercise testing 
Patients were tested on two occasions, one week apart, according to the methods detailed in 
Chapter 2. All tests were performed at the same time of day, two hours after the last dose of 
medication had been ingested. On the first day, patients underwent anthropometric assessment 
and performed a graded exercise test to exhaustion on a cycle ergometer for determination of 
peak oxygen consumption, heart rate and blood pressure responses and ratings of perceived 
exertion during exercise. Blood sampling for measurement of blood lactate concentration was 
performed during exercise. 
During the second testing session, patients performed tests of isometric and isokinetic skeletal 
muscle function as detailed in Chapter 2. At least one hour was allowed for patients to recover 
between exercise bouts. Equipment malfunction interrupted respiratory gas testing in two control 
subjects. 
Radionuclide angiocardiography for determination of resting left ventricular ejection fraction was 
performed only in the patients with CHF one week prior to the exercise test, according to 
conventional techniques. 
Statistical analysis 
All data are expressed as mean ± SEM. The significance of differences between experimental 
variables of the two groups were analyzed using a Student's unpaired t-test with two-tailed p 
values. Statistical significance was established at the 0.05 and 0.01 confidence levels (Glanz 
1980). ,, 
Results 
Anthropometrical Analysis 
Anthropometrical data are detailed in Table 3.3. Both the patient and the control groups displayed 
predominantly mesomorphic somatotypes. Waist-hip ratio, % body fat, lean body mass and 
anthropometrical estimation of muscle mass were not significantly different between groups. 
However,Jean thigh volume (LTV) was significantly lower in the patient group compared to the 
control group (p<0.05). 
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Table 3.3 Anthropometrical data displaying somatotype and morphometry 
Patient Endo Meso Ecto WHR LTV (cc) % Body Fat LBM (kg) AEMM (kg) Ht(m) 
1 4.5 3.3 2.9 0.94 2886 26.0 52.5 29.7 1.77 
2 1.6 1.7 4.2 0.97 3164 13.0 54.9 27.9 1.77 
3 4.5 5.9 0.0 0.90 3725 23.8 51 .8 33.5 1.58 
4 5.7 3.6 1.6 0.90 2326 27.2 47.1 25.1 1.65 
5 3.1 4.1 0.1 0.93 2318 20.5 55.6 28.1 1.77 
6 3.9 4.1 2.1 0.99 3981 23.6 64.9 39.4 1.83 
7 5.3 5.9 0.1 1.03 4052 28.5 69.0 41.5 1.78 
8 8.4 9.0 0.1 0.94 3499 35.8 77.0 44.4 1.74 
9 2.6 5.1 0.3 1.16 3098 18.1 71.7 36.0 1.74 
10 6.7 6.2 0.5 0.96 2893 26.6 77.8 34.6 1.87 
11 6.2 7.3 0.1 1.08 3502 32.0 76.8 32.0 1.84 
Mean 4.8 5.1 1.1 0.98 3222* 25.0 63.6 33.8 1.74 
SEM 0.6 0.6 0.4 0.02 171 1.8 3.3 1.8 0.9 
Control 
1 7.8 8.3 -2.7 1.02 4456 33.9 79.4 45.2 1.74 
2 1.7 3.3 4.6 0.79 4244 9.8 56.4 28.6 1.80 
3 3.0 5.3 1.2 0.90 5429 20.5 63.6 38.5 1.76 
4 3.8 4.8 1.0 0.89 4800 21 .5 74.5 35.9 1.84 
5 1.4 4.7 2.4 0.88 4764 14.0 64.5 37.6 1.79 
6 4.7 5.9 0.1 1.03 4754 22.7 70.6 36.8 1.72 
7 5.9 5.0 0.9 0.88 3818 24 .0 64.6 37.6 1.81 
8 3.8 4.7 0.2 0.97 2821 22.1 53.6 24.4 1.69 
9 7.0 6.9 0.1 1.03 3348 31.0 70.0 35.7 1.84 
10 4.7 8.3 1.3 0.95 4066 14.8 60.5 34.1 1.80 
Mean 4.4 5.7 0.9 0.93 4250 21.4 65.8 35.4 1.78 
SEM 0.7 0.5 0.6 0.03 244 2.3 2.5 2.4 1.55 
Abb!ev1alions : Endo, endornorphy, Meso, mesomo1phy, Eclo, ectomorphy, WHR, waist hip raho, LTV, lean thigh volume; cc 
cubic cenhlllres; LBM, lean body mass; kg,k1logram , AEMM, anlhropometrical eslimat1on ol muscle mass; SEM, standard error 
of the mean. • = p<0.05 CHF vs control subjects 
Resting cardiovascular measurements 
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Wt(kg) 
71 
63 
68 
65 
69 
85 
97 
120 
80 
106 
113 
85 
6 
118 
63 
80 
94 
75 
92 
102 
69 
85 
78 
86 
5 
Resting cardiovascular measurements are listed in Table 3.4. Resting heart rate (HR) in the CHF 
group was significantly higher than the control group (p<0.05). Both resting systolic (SBP) and 
diastolic blood pressure (DBP) were significantly lower in the CHF group compared to the control 
group (p<0.05). 
Table 3.4 Resting cardiovascular measurements 
HR (b/min) SBP (mmHg) DBP (mmHg) 
Patient Group 80 ± 3• 111 ± 4• 73 ± 4 • 
Control Group 70 ± 3 124 ± 2 82 ± 1 
Abbrevialtons: HR, heart rale: SBP, systolic blood pressure: DBP, diastolic blood pressure: b/min, beats per min:mmHg, 
millimetres of mercury • = p<O 05 paltenls vs conlrol subjecls 
Exercise performance and cardiovascular and respiratory measurements during 
submaximal exercise 
The exercise test protocol for both patient and control groups was identical (Chapter 2). Data are 
expressed at the same absolute workload (Figs 3.1 ,3,5,7,9, 11 , 13) and at the same relative 
intensity of exercise: at 25, 50, 75, and 100 percent of peak oxygen consumption (%V02 peak; 
Figs 3.2,4,6,8,10,12,14). 
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Although HR tended to be higher at any given absolute workload during exercise in the patients 
compared to control subjects, it was only significantly higher at workloads of 5W and 80W (p<0.05, 
Fig 3.1 ). HR was significantly increased compared to control subjects at 25% of V02 peak, 
(p<0.05; Fig 3.2), but was lower than that of control subjects at 100% of V02 peak (p < 0.05; Fig 
3.2). SBP was significantly lower in the patients compared to control subjects at workloads of 10, 
20, 30, 40 and 50 W (p<0.05), but not thereafter (Fig 3.3). However, SBP was significantly lower in 
the patients compared to control subjects at all relative intensities of exercise (p<0.05; Fig 3.4). 
Although oxygen consumption (V02 ) tended to be higher in the control group, it was not different 
between groups at any given absolute workload (Fig 3.5). However, patients had significantly 
lower values compared to control subjects at all relative exercise intensities(p<0.05; Fig 3.6). 
Minute ventilation (Vi) was not different between groups at any given workload (Fig. 3. 7). However, 
Vi was significantly lower in the patients compared to the control group at any relative exercise 
intensity above 50 % V02 peak (p<0.001 ; Fig 3.8). 
Respiratory exchange ratio (RER) tended to be higher throughout exercise in the patients with 
chronic heart failure, and was significantly higher at 40, 50, 70, 80 and 90 W compared to the 
control subjects (p<0.05; Fig . 3.9) . At work intensities of 75 and 100 % V02 peak, RER was 
significantly lower in the patients compared to the control subjects (p<0.05; Fig 3.10). 
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Fig 3.3-3.4. Systolic blood pressure responses depicted against increasing workload during graded exercise to exhaustion in patients with heart failure compared to controls . Data are expressed at the same absolute workload (Figs 3.3), and at the same relative intensity of exercise: 25, 50, 75, and 100 percent of maximum oxygen consumption (Figs 3.4 ). Data are displayed until > 50% of the patients and controls terminated the exercise test. Abbreviations: mmHg, millimeters of mercury: % vo2 max, percent of the maximum of oxygen consumed in one minute. *=p<0.05 **=p<O.OJ Heart failure vs Control. All values are expressed as mean and standard error of the mean. 
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Fig 3.5-3.6. Oxygen consumption depicted against increasing workload during graded exercise to exhaustion in patients with heart failure compared to controls . Data are expressed at the same absolute workload, and at the same relative intensity of exercise: 25, 50, 75, and 100 percent of maximum oxygen consumption . Data are shown until> 50% of the subjects terminated the exercise test . Abbreviations: vo2, volume of oxygen; ml.02'kg/min, millilitres of oxygen consumed per kilogram of body weight per minute; % vo2 max, percent of the maximum of oxygen consumed in one minute. ·=p<0.05 Heart failure vs Control. All values are expressed as mean and standard error of the mean. 
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Fig 3.13-3.14. Rate of perceived exertion depicted against in
creasing workload during graded exercise to exhaustion in 
patients with heart failure compared to controls. Data are e
xpressed at the same absolute workload, and at the same 
relative intensity of exercise: 25, 50, 75, and 100 percent o
f maximum oxygen consumption. Data are displayed until>
 
50% of the patients and controls terminated the exercise te
st. Abbreviations: % V02 max, percent of the maximum 
volume of oxygen consumed in one minute. •=p<0.05 .. =p<O
.O l Heart failure vs Control. All values are expressed as 
mean and standard error of the mean. 
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Although blood lactate concentrations were not different between groups at any given workload 
(Fig 3.11 ), concentrations were higher in the control group at exercise intensi• es above 50 % V02 
peak (p<0.05; Fig 3.12). 
Ratings of perceived exertion (RPE) were significantly higher in the patients compared to control 
subjects at any absolute workload during the cycle test (Fig 3.13). However, control values were 
significantly higher at 50 and 75 %V02 peak (p<0.05; Fig 3.14). 
Exercise performance and cardiovascular and respiratory measurements at the peak 
exercise workload 
All patients and control subjects completed the maximal exercise tests to exh8'!stion. 
Cardiorespiratory responses and perception of effort at the peak workload ar~ ~is~ed in Table 3.5. 
Peak workload and exercise time completed by the patient group was signifo:antly lower compared 
to the control group (p<0.01 ). Mean peak HR and mean peak SBP were also !>ignificantly lower in 
the patients compared to the control subjects (p<0.01; p<0.05 respectively) ,,02 peak and 
maximum Vi were significantly lower in the patients compared to control subjf;cts at peak workload 
(p<0.01 ), as was the respiratory exchange ratio (RER; p<0.05). Peak blood l2ctate concentrations 
were significantly lower in the patient group compared to controls (p<0.01 ). 
Seven patients terminated exercise due to leg muscle fatigue, two patients complained of fatigue of 
the arm muscles from holding onto the bicycle handle-bars, that is, this was not :-.;chaemic pain, 
and two patients complained of general fatigue. Eight control subjects term:rnt:;;d exercise 
complaining of general fatigue, whilst two subjects complained of leg fatigue . 
... 
Table 3.5. Cardiorespiratory measurements and performance variables at the peak exercise 
workload 
PeakWL Exercise V02peak RER Plasma 
Patient (Watts) time HR SBP (m/02 Vi (VCOt Lactate 
(min) (blmin) (mmHg) /kg/min) (Umin) V02) (mmol/l) 
1 30 6 124 110 8.5 31.8 1.06 4.1 
2 50 8 141 115 11.4 37.3 1.01 4.9 
3 80 11 162 148 17.8 28.9 1.01 5.2 
4 60 9 145 110 11.1 33.1 1.02 5.2 
5 80 11 130 110 12.9 24.7 0.95 6.4 
6 50 8 137 85 10.6 34.9 0.97 3.3 
7 50 8 106 90 8.4 32.8 0.98 2.7 
8 100 13 134 200 13.8 39.8 1.06 3.9 
9 40 7 120 110 10.1 28.8 0.86 3.1 
10 140 16 182 210 17.6 54.5 1.11 8.1 
11 120 15 138 210 14.9 50.8 1.03 3.9 
Mean 73** 10** 138** 136* 12.5** 36.1** 1.01* 4.6** 
SEM 10 1 6 14 1.0 2.7 0.01 0.5 
Control 
1 170 20 157 230 20.0 59.0 1.05 6.8 
2 275 25 188 160 51 .0 103.2 1.00 7.8 
3 265 24 159 190 39.0 83.8 1.10 6.7 
4 200 16 200 200 - - - -
5 275 25 180 180 37.0 71.2 1.20 8.2 
6 195 17 195 195 - - - 7.8 
7 230 26 143 190 33.8 82.4 1.10 7.6 
8 150 18 172 170 27.1 67.0 1.20 7.8 
9 240 27 180 210 26.6 72.7 1.18 5.9 
10 240 27 176 220 39.7 90.2 1.12 7.2 
Mean 224 23 175 194 34.3 78.7 1.12 7.3 
SEM 14 1 6 7 3.5 5.0 0.03 0.3 
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Abbrev1ahons:WL, workload; V02 peak, peak oxygen consumption; SBP, systolic blood pressure; HR, heart rate; b/min, beats per minute; 
ml02"kg/min, millilitres of oxygen consumed per kilogram of body weight per minute of exercise; Vi , ventilation; I/min, litres per minute; RER, 
respiratory exchange ratio; vco2• volume of carbon dioxide; mmol/1, millimole per litre; SEM, standard error of the mean. Values are expressed as 
the mean ± SEM. • = p<0.05 •• = p<0.01 patient vs control. 
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Skeletal muscle function 
Parameters of isokinetic and isometric skeletal muscle function are listed in Table 3.6. lsokinetic 
peak torques of the quadriceps and hamstring muscle groups in patients were significantly lower 
than in controls (p<0.05). However, when corrected for lean thigh volume, values were not 
significantly different from controls. Total work performed during 25 contractions by the quadriceps 
and hamstring muscle groups was also sigificantly lower in the patients (p<0.05). But when 
corrected for lean thigh volume, total work of the quadriceps and hamstring muscles was still 
significantly lower than in the control subjects (p<0.05). 
Isometric maximum voluntary contraction (MVC) generated by the quadriceps muscle group was 
significantly lower in patients than in controls (p< 0.001 ). However, when corrected for LTV, the 
MVC was no longer statistically different between groups. 
Time to fatigue measured during repeated maximal isometric relaxation/ contraction cycles was 
also significantly lower in patients compared to controls (p<0.05). 
Table 3.6. Isometric and isokinetic tests of skeletal muscle function 
PKTQI PKTHI TWQ I TWHI MVC I 
PKTQ LTV PKTH LTV TWQ LTV TWH LTV MVC LTV TTF 
Patient (Nm) (Nm/cc) (Nm) (Nm/cc) (J) (J!cc) (J) (J!cc) (Nm) (Nm/cc) (sec) 
1 . . . . . . . . . . . 
2 94 30 51 16 1161 366 448 142 110 35 30 
3 120 32 48 13 1222 331 298 93 150 40 91 
4 135 58 37 16 2075 894 480 206 110 47 62 
5 121 52 67 29 1541 664 448 195 110 48 30 
6 133 33 36 9 1500 376 976 245 120 30 68 
7 105 25 54 15 1175 289 124 31 120 30 59 
8 196 56 85 27 2223 635 458 131 120 34 59 
9 105 33.9 40 13 900 257 111 36 . . . 
10 192 66.4 90 26 2380 823 1300 371 190 66 75 
11 124 35.4 85 29 1467 419 1396 483 180 51 139 
Mean 133* 42 60 * 19 1565* 506* 604* 192* 134** 42 68 * 
SEM 15 6 8 2 166 70 163 41 12 5 12 
Control 
1 168 40 78 19 2641 633 1570 376 230 55 116 
2 291 69 169 40 4662 1099 3619 853 190 45 80 
3 292 54 169 31 3998 737 3018 556 170 31 160 
4 230 48 149 31 3185 664 2749 573 230 48 75 
5 225 47 131 28 3615 759 2414 507 150 32 150 
6 292 61 150 32 3467 729 2617 550 145 31 70 
7 112 28 66 16 2300 566 1619 398 168 41 92 
8 102 37 33 12 1241 446 431 155 200 72 75 
9 156 41 65 17 2302 603 913 239 210 55 80 
10 163 49 68 20 1504 501 1084 324 248 75 97 
Mean 203 47 108 25 2892 674 2003 453 194 49 100 
SEM 23 4 16 3 345 59 326 63 11 5 10 
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Abbrev1ahons. PKTQ, peak torque produced by the quadriceps muscles : PKTH, peak torque produced by the hamstring rnuscles;Nm, Newlon-metres: 
LTV, lean thigh volume: cc. cubic cenlimetres , TWO, total work performed by the quadriceps muscles;TWH, total work performed by the hamstring 
muscles : MVC, maximum voluntary contraction, TTF . lime lo fatigue: SEM, standard error of the mean. Values are expressed as the mean± SEM. • = 
p<0.05 •• =p<O 001 palient vs control. 
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Discussion 
The first important finding of this study was that exercise tolerance was significantly reduced in 
patients with CHF and appeared to be limited by peripheral (skeletal muscle) rather than by central 
factors. Evidence for this conclusion was found during the incremental cycle test to exhaustion and 
during isokinetic testing of skeletal muscle function. This conclusion conflicts with the more 
traditional view that central cardiovascular factors may limit the exercise capacity of patients with 
CHF (Packer 1990; Wilson et al. 1984b; Weber et al. 1982). 
Thus patients with CHF terminated progressive cycle exercise to exhaustion at heart rates, rates of 
ventilation, respiratory exchange ratios and, most especially, blood lactate concentrations that 
were significantly lower than values achieved by control subjects during maximal dynamic exercise 
(Table 3.5). Furthermore, rates of 02 consumption did not plateau during graded maximal 
exercise. If central cardiovascular function limited their exercise performance, one would have 
expected a plateau of 02 consumption and values for all these measurements to be higher in 
patients with CHF than in the control subjects. Indeed, if skeletal muscle blood flow was impaired 
as a result of CHF, according to the proposal that anaerobic conditions in muscle favour skeletal 
muscle lactate production, one might have expected blood lactate concentrations to be very high at 
fatigue in patients with CHF. But this was not found. Other research in this laboratory (Kempeneers 
et al. 1990; Diesel et al. 1990) has previously used this line of reasoning to argue that patients with 
chronic renal disease also have a myopathy that limits their exercise tolerance (Diesel et al. 1993). 
Kavanagh and Yacoub (1992) reported a similar finding in cardiac transplant patients and have 
also concluded that the exercise tolerance of these patients is limited by peripheral factors. 
More direct evidence for a peripheral, skeletal muscular limitation was the finding on isokinetic 
muscle function testing. Performance in these tests is, not considered to be limited by central 
cardiovascular function as only a small muscle mass is active during exercise. We found that 
isokinetic peak torque and the MVC of the quadriceps muscles was significantly reduced in 
patients compared to controls (Table 3.6). But when corrected for lean thigh volume, MVC and 
peak torques were no longer significantly different from control values, as also found by Minotti et 
al. (1991 b). 
This finding is therefore similar to others which have demonstrated that maximal force production 
per unit muscle cross-sectional area is probably within the normal range in patients with CHF 
(Magnusson et al. 1994; Buller et al. 1991) but that muscle mass is reduced, thereby reducing the 
total force production by muscle in such patients. However Poole-Wilson et al. (1988) reported that 
even when corrected for the (reduced) lean thigh volume, isokinetic skeletal muscle function was 
still impaired in cardiac patients. 
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Although force production measured during maximum contractions of short duration was not 
different to control subjects, the total work performed during repeated maximal isokinetic 
contractions was significantly lower in patients than in control subjects. These differences 
persisted even when measurements were corrected for differences in lean thigh volume. This 
indicates that as the tests of muscle function become prolonged and include an endurance 
component, the muscle function of these patients becomes progressively more abnormal. This 
would indicate that, whilst the skeletal muscles of patients with CHF retain the ability to produce 
maximum force, they fatigue more rapidly and therefore produce less force during subsequent 
consecutive contractions. As a result. the total work performed during a more prolonged test of 
skeletal muscle function, is reduced. This finding was confirmed by the test of repetitive isometric 
contraction/relaxation cycles in which time to fatigue was significantly shorter in patients with CHF 
(Table 3.6). 
Thus our results indicate that the resistance to the onset of fatigue (Coetzer et al. 1993; Derman et 
al. 1993) is altered in these patients. It is possible that a smaller percentage of Type I fibres in 
patients with CHF (Mancini et al. 1989; Sullivan et al. 1990a) which would be expected to cause a 
more rapid rate of phosphocreatine depletion during exercise (Mancini et al. 1992; Rajagopalan et 
al. 1988) may explain this finding. 
We also found that the lean thigh volume of patients was significantly less than in controls. 
Anorexia, physical inactivity, increased catabolic state, and increases in the serum concentrations 
of cortisol, ACTH and tumor necrosis factor could possibly all contribute to muscle atrophy in 
patients with CHF (Mancini et al. 1992; Peterson et al. 1988; Levine et al. 1990; Francis et al. 
1990). It is unlikely that inactivity alone contributed to the reduction in skeletal muscle mass since 
the control subjects were also inactive. 
It has been suggested that the reduced skeletal muscle mass alone could explain the exercise 
intolerance of these patients (Martin et al. 1989; Jondeau et al. 1992; Mancini et al. 1988; Massie 
et al. 1987a). However, Mancini et al. (1992) did not find a significant correlation between V02 
peak and lean body mass, weight. or triceps skinfold thickness and concluded that skeletal muscle 
atrophy contributes modestly to both the reduced exercise capacity and the altered skeletal muscle 
metabolism of patients with CHF. Our finding that one fundamental characteristic of skeletal 
muscle function, namely fatigue resistance, is altered in CHF, is compatible with this conclusion. 
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The second important finding of this study is that submaximal 02 consumption and minute 
ventilation are not different in patients with CHF compared with controls at low work rates. Indeed 
our data suggest that 02 consumption, minute ventilation and blood lactate concentrations are 
appropriate for low workloads in these patients. But when considering these variables at exercise 
intensities relative to percentage V02 max, 02 consumption, minute ventilation and blood lactate 
concentrations are decreased in patients with CHF compared to controls. These findings are 
probably due to the greater absolute maximum workload achieved by the controls or, stated 
differently, indicate that the maximal workloads achieved by the patients in heart failure are 
abnormally low. 
It has been suggested that poor exercise tolerance and increased perception of effort might be 
explained by early onset of anaerobic metabolism and metabolic acidosis (Koike et al. 1990). Many 
recent studies have noted a close association between early metabolic acidosis and abnormal 
exercise capacity in patients with CHF (Weber and Janicki 1985; Roubin et al. 1990; Weber et al. 
1982; Wilson and Ferraro 1983; Wilson et al. 1984). Our data indicate that at identical work rates 
(0-1 OOW), blood lactate concentrations, rates of 02 consumption and minute ventilation were not 
different between patients and controls (Figs 3.5-3.12). The equivalent blood lactate 
concentrations during submaximal exercise in patients with chronic heart failure and controls 
provide no evidence for early anaerobiosis during exercise in the patients with CHF. Rather, our 
findings demonstrate a gradual and appropriate increase in blood lactate concentrations during 
graded exercise in these patients. Similar findings were described by Simonton et al. (1988). 
However, Sullivan et al. (1989) demonstrated that systemic venous lactate concentrations and the 
rate of lactate production by the active skeletal muscles was increased in patients with CHF 
compared to control subjects at low workloads, while whole body V02 (ml/min) values were not 
different between groups at those low workloads. But the V02 of the active muscle mass was less 
in patients than in controls. The authors conclude that early anaerobiosis causing increased lactate 
production and accumulation does indeed occur in patients with CHF. 
These findings are at variance with the findings in the present study which show no evidence of 
altered rates of oxygen consumption and systemic venous lactate accumulation in patients with 
CHF compared with controls. This might be due to the different exercise protocols and patient 
characteristics from the above mentioned study. However it is possible that differences in blood 
lactate production and 02 consumption might only be evident when measured directly over the 
active skeletal muscle in the femoral arterial and venous blood. It is further possible that these 
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changes are not mirrored by changes in systemic venous lactate concentrations, perhaps due to 
increased clearance of lactate by the liver. This would only be resolved by using the same invasive 
techniques as those used by Sullivan et al. (1989). 
Sullivan et al. (1989) did not report ratings of perceived exertion during exercise. The present study 
shows that ratings of perceived exertion at identical work rates are significantly higher in patients 
with CHF compared to controls, while blood lactate concentration, 02 consumption and minute 
ventilation are the same. This finding indicates that factors other than increased blood lactate 
concentrations, 02 consumption and minute ventilation are responsible for increased perception of 
effort during graded exercise in patients with CHF. 
In summary, patients with CHF have altered skeletal muscle function, including a decreased 
resistance to the onset of fatigue. Furthermore, graded exercise to exhaustion in these patients 
seems to be limited more by peripheral rather than central factors. It is possible that skeletal 
muscle structural abnormalities might be related to these abnormalities of skeletal muscle function. 
This possiblitiy will be addressed in Chapter 4. 
CHAPTER 4 
STRUCTURAL ABNORMALITIES OF SKELETAL MUSCLE IN PATIENTS WITH CHRONIC 
HEART FAILURE: RELATIONSHIP TO EXERCISE PERFORMANCE 
\ 
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Introduction 
As described in Chapter 1, studies have documented gross changes in the histology of the skeletal 
muscles in patients with chronic heart failure (CHF) (Lipkin et al. 1988; Drexler et al. 1992), but few 
studies have provided a detailed description of these changes, and none have provided equivalent 
information from appropriate control groups. Furthermore, few studies have examined the 
ultrastructure of the skeletal muscle in patients with CHF. 
Minotti et al. (1991 a) and others have shown that the extent of metabolic abnormalities in the 
skeletal muscle correlate with the extent of exercise intolerance in these patients and could 
contribute to their impaired exercise tolerance (Wiener et al. 1986; Massie et al. 1987 a, b; Sullivan 
et al. 1990, 1991 ; Drexler et al. 1988, 1992; Mancini et al. 1992; 1994). Furthermore, Drexler et al. 
(1992) reported a relationship between mitochondrial volume density and V02 peak in patients 
with CHF. 
But it is not known if the severity of the histological abnormalities of the skeletal muscles in patients 
with CHF relate to the exercise intolerance experienced by these patients. Only crude methods for 
quantification of skeletal muscle structural damage exist which do not include all histological 
features of the skeletal myopathy (Sapega et al. 1985). We therefore sought to create a method for 
quantification which would include all aspects of skeletal muscle structural damage. 
Accordingly, the purpose of this study was (i) to describe the histological and ultrastructural 
findings in skeletal muscle biopsy samples from patients with CHF; (ii) to develop a simple 
histological grading system to quantify the magnitude of these changes, thereby allowing the 
prospective assessment of changes due to drugs, exercise training or disease progression; and 
(iii) to determine the relationship of these changes to alterations in the exercise capacity of these 
/ 
patients. 
Skeletal muscle biopsy procedures 
Skeletal muscle biopsy of the vastus lateralis was performed according to the methods described 
in Chapter 2. A skeletal muscle biopsy was only performed if the clotting factor (INR; International 
Ratio) was <2.0. Ten of the patients with CHF studied in Chapter 3 consented to a skeletal muscle 
biopsy, whilst a skeletal muscle biopsy could not be performed on one patient who had an INR > 
2.0. Eight control subjects consented to a skeletal muscle biopsy. 
... 
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Histological scoring of skeletal muscle biopsy samples 
The skeletal muscle biopsy samples for light microscopic analysis from both patients and controls 
subjects were numbered, randomized and examined by two pathologists who had no knowledge of 
the origin of the biopsies. Each specimen was closely examined for the presence of the 
characteristics of the skeletal myopathy associated with CHF, namely: fibre atrophy, fibre 
hypertrophy, fibre necrosis, fibre grouping, fibre splitting, presence of moth-eaten fibres, fibrosis, 
nuclear abnormalities including presence of nuclear chains, knots, vesicular and internal nuclei, 
phagocytosis, lipid inclusions, basophilia and capillary thickening. Each identified abnormality was 
graded according to the following system; 1 = mild, 2 = moderate, 3 = severe. Skeletal muscle 
pathology scores were then summed for each specimen and the mean score of the pathologists 
was taken as the pathology score for that patient or control subject. 
Results 
Morphometry of skeletal muscle fibre type, size, distribution and predominance is described in 
Table 4.1 
Skeletal muscle fibre morphometry 
Measurement of the skeletal muscle fibres stained for myosin ATPase, from the patient group 
revealed a mean Type I fibre size of 67 ± 3 µm and a mean Type II fibre size of 60 ± 4 
micrometres (µm). One patient had significant Type II fibre atrophy (mean diameter= 40 µm; 
Dubowitz et al. 1985) and one patient had significant hypertrophy of both Type I and II muscle 
fibres. The mean percentage of Type II skeletal muscle fibres in the patient group was 65 ± 4 %. 
Two patients displayed Type II fibre predominance (>80%). Seventeen± 6% of Type II fibres were 
atrophic, whilst 17 ± 7% of Type II fibres were hypertrophic. Only 2 ± 1% of Type I fibres showed 
significant atrophy whilst 10 ± 2% of Type I fibres were hypertrophied. 
Morphometric analysis of control biopsies revealed a mean Type I fibre size of 70 ± 9 µm and a 
mean Type II fibre size of 70 ± 9 µm. One subject had significant hypertrophy of Type II muscle 
I 
fibres. The mean percentage of Type II skeletal muscle fibres was 56 ± 4 %. 
Table 4.1 Morphometry of skeletal muscle fibre type, size, distribution and predominance 
Fibre Size (micrometres) Fibre Distribution Predominance 
Patient Type/ Type II Type/ Type II Total fibres Type/% Type II% 
1 66 66 48 104 152 32 68 
2 53 41 80 102 182 44 56 
3 90 81 64 110 174 38 63 
4 67 56 41 106 147 28 72 
5 58 49 48 100 148 32 68 
6 61 66 62 100 162 38 62 
7 66 55 112 80 192 58 42 
8 68 40 32 141 173 18 82 
10 70 78 19 106 125 15 85 
11 72 67 79 99 178 44 56 
Mean 67 60 59 105 163 35 65 
SEM 3 4 8 5 6 4 4 
Control 
1 81 75 46 92 138 33 67 
2 73 70 83 117 200 42 56 
3 63 78 115 85 200 58 42 
4 74 77 71 100 171 42 58 
7 63 47 55 103 158 35 65 
8 73 80 51 69 120 43 58 
9 60 65 103 82 185 56 44 
10 68 66 72 99 180 48 50 
Mean 70 70 75 93 168 44 56 
SEM 3 3 10 12 12 4 4 
Light Microscopy 
/ 
Details of the light microscopic findings of individual biopsies are presented in Table 4.2. Normal 
size and distribution of skeletal muscle fibres from a control subject is depicted in Figure 4.1. 
Atrophic and hypertrophic fibres were present in all patients and most also had fibres showing 
splitting and central nuclei (Figure 4.2). The atrophied and hypertrophied fibres were usually both 
Types I and II but Type II fibres were more severely atrophic. The fibres of two patients showed 
marked hypertrophy. 
Nuclear chains or nuclear clumps, some pyknotic, were prominent. Occasional fibres appeared 
necrotic and phagocytes were present. Atrophic fibres showed disturbed patterns of NADH 
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staining and occasional fibres had architectural changes. Degenerative features were uncommon 
(Figure 4.3). 
Some patients appeared to have more lipid droplets within the fibres than did control subjects. 
Thickening of the capillary basement membrane was visible on light microscopy in all but one 
patient. Slits or cracks in fibres containing NADH positive material were also seen in a number of 
patients. 
One control biopsy displayed scanty necrotic fibres, fibre splitting and some moth-eaten fibres, and 
another showed a mild increase in lipid and thickening of the capillary basement membranes. The 
extent and severity of these changes were not as pronounced as the abnormalities present in the 
biopsies from the patient group. 
Electron Microscopy 
The electron microscopic findings are presented in Table 4.3. The ultrastructural changes include 
the presence of nuclear chains with folding of the nuclear membranes and nuclear clumps. In 
some patients, clumping was associated with chromatin margination. Dissolution of the 
myofilaments and Z-bands was present in 7 patients. Glycogen aggregation was both 
subsarcolemmal and intermyofibrillar (Figure 4.4). Examination of the mitochondria revealed a 
spectrum of changes comprising swelling, disruption and a loss of cristae, abnormal cristae 
formation and whorled inclusions (Figures 4.4 & 4.5). Lipid accumulation was mainly in the 
subsarcolemmal region. 
Some biopsies contained abundant lipofuscin. Subsarcolemmal filamentous bodies consisting of 
whorled microfilaments were present in three patients (Figure 4.6); these were associated with 
sarcolemmal folding in two cases and redundant sarcoplasmic basement membranes in one case 
(Figure 4.7). Two others revealed thickening of the sarcoplasmic basement membranes while five 
showed increased collagen in the interstitium (Figure 4.7). Macrophages and mast cells were also 
frequently present in the interstitium. 
The capillary basement membranes of all patients were strikingly thickened. Reduplication, 
entrapped debrinous material together with swollen lucent capillary endothelium were also seen 
(Figure 4.8). Ultrastructural morphometry revealed capillary basement membrane width varying 
from 194 to 840 nm (mean± SEM width 409 ± 13 nm). 
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Table 4.2 Light microscopic analysis of individual skeletal muscle biopsy samples 
Patient Light Microscopy Pathology 
score 
(arbitrary units) 
1 Mild fibre atrophy (moth eaten on NADH), moderate hypertrophy, fibre splitting, 16 
internal nuclei , nuclear chains and pyknotic knots. Occasional necrotic fibres with 
phagocytes and occasional fibres with architectural changes. Marked capillary 
basement membrane (CBM) thickening. 
2 Marked atrophy with mild hypertrophy, fibre splitting, pyknotic nuclear knots. 13 
Basophilic fibres, fibre size variation, occasional phagocytes. Some adipose 
infiltration. CBM thickening. 
3 Occasional atrophic or split fibres, prominent hypertrophied fibres, moth eaten fibres 8 
(NADH stain), central nuclei. Moderate numbers of nuclear chains and pyknotic 
clumps. Occasional architectural changes. CBM thickening slight. 
4 Occasional atrophic hypertrophic or regenerating fibres. Some nuclear chains and 8 
pyknotic knots. Occasional necrotic cells with phagocytes. Marked CBM thickening. 
5 Extensive atrophy (with I and II), moderate fibre splitting, occasional moth eaten 11 
fibres (NADH) and pyknotic nuclear clumps. Occasional necrotic fibres with 
phagocytes. Moderate CBM thickening. 
6 Mild atrophy (chiefly Type II), some hypertrophy, moderate fibre splitting, internal 17 
nuclei, nuclear chains and pyknotic clumps. Occasional necrotic cells. Moth eaten 
fibres (NADH). Mild CBM thickening. 
7 Fibre size variation, mild atrophy and hypertrophy, moderate fibre splitting, internal 12 
nuclei, nuclear chains and pyknotic knots. Occasional necrotic cells with 
phagocytes. Moderate CBM thickening. 
9 Marked atrophy with some hypertrophy, moderate numbers of necrotic cells with 26 
phagocytosis, marked fibre splitting, internal nuclei, nuclear chains and pyknotic 
clumps. Moth eaten fibres (NADH) and some architectural changes. Marked CBM 
thickening. 
10 Mild atrophy, marked hypertrophy, prominent internal nuclei and necrotic fibres with 6 
phagocytosis, some pyknotic nuclear clumps. 
11 Moderate atrophy and hypertrophy, scattered necrotic fibres with phagocytes, 6 
occasional fibre splitting and pyknotic nuclear clumps. Mild CBM thickening. 
Control 
1 Normal skeletal muscle. 0 
2 Normal skeletal muscle 0 
3 Normal skeletal muscle, few split fibres . 1 
4 Normal skeletal muscle 0 
7 Mild increase in internal nuclei and lipid, early ragged red fibers, arterioles 3 
thickened. 
8 Some necrotic fibers, some of which are moth-eaten on NADH stains, and a small 5 
amount of splitting is present. (This patient was diagnosed with cancer of the 
stomach eight months after this biopsy was periomed). 
9 Normal skeletal muscle. 0 
10 Normal skeletal muscle. 0 
Table 4.3. Electron microscopic analysis of individual skeletal muscle biopsy samples 
Patient 
1 
2 
3 
4 
5 
6 
7 
9 
10 
11 
Control 
1 
2 
3 
4 
7 
8 
9 
10 
Electron Microscopy 
Nuclear chains, Subsarcolemnmal lipid accumulation,lntermyofibrillar glycogen aggregation 
macrophages, Numerous lipofuscin granules, Degenerate muscle cells, Capillary basement 
membrane thickening. 
Z-band streaming, Redundant sarcoplasmic basement membranes, Increased interstitial collagen 
and glycoimmunoglycans, Macrophages, Mast cells, Thickening and multilayering of the capillary 
basement membrane which contain entrapped debrinous material. 
Loss of myofilaments and Z-banding, Increased lipid accumulation and intermyofibrillar glycogen 
aggregates, Mitochondrial inclusions, Filamentous bodies, Numerous subsarcolemmal myelin 
inclusions, Sarcolemmal folding, Macrophages, Capillary basement membrane thickening with 
mild multilayering. 
Nuclear pyknosis and cellular degeneration, Myofilament and Z-band dissolution, Large 
mitochondrial myelin inclusions, Subsarcolemmal vacuolation, Filamenious bodies, Sarcolemmal 
folding, Macrophages containing haemosiderin pigment, Increased interstitial collagen, Capillary 
basement membrane thickening with entrapped granular debris. 
Increased lipid accumulation, Subsarcolemmal glycogen aggregation, Mast cells, Thickened 
capillary basement membranes, Swollen capillary endothelium. 
Nuclear chains, Myofilament and Z-band loss, Small mitochondrial inclusions, Subsarcolemmal 
lipid accumulation and vacuolation, Numerous lipofuscin pigment, Thickening of the sarcolemmal 
basement membranes, Redundant sarcoplasmic basement membranes, Increased interstitial 
collagen and glycosaminoglycans, Myoblasts, Macrophages, Capillary basement membrane 
thickening with multilayering and entrapped granular material. 
Extensive myofilamentous and Z-band dissolution, Mitochondrial myelin inclusions, Lipid 
accumulation, Glycogen aggregates, Sarcolemmal folding, Increased interstitial collagen, Capillary 
basement membrane thickening and multilayering. 
Margination of the nuclear chromatin, A loss of myofilaments and Z-banding, Whorled 
mitochondrial inclusions, Numerous lipofuscin granules, Sarcolemmal folding and thickening of the 
sarcolemmal basement membranes, Increased interstitial collagen, Macrophages, Severe 
thickening of the capillary basement membranes with entrapped debrinous material and collagen 
fibres, Swollen capillary endothelial cells. 
Loss of myofilaments and Z-banding, Splitting of the myofibrils, Numerous pleomorphic 
mitochondria, Lipid accumulation, Increased interstitial collagen and glycosaminoglycans, 
Thickened capillary basement membranes. 
Loss of myofilaments and Z-banding, Lipid accumulation, Subsarcolemmal glycogen aggregates, 
Filamentous bodies, Degenerate cells, Macrophages, Mast cells, Capillary basement membrane 
thickening and swollen endothelium. 
Normal skeletal muscle with increased lipid. 
Normal skeletal muscle 
Normal skeletal muscle 
Normal skeletal muscle with mast cells and a single cell with increased subsarcolemmal glycogen 
aggregation 
Normal skeletal muscle. 
Normal with some disrupted mitochondria. 
Normal skeletal muscle. 
Normal with some disrupted mitochondria. 
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Evidence for muscle regeneration was present. Regenerated myocytes showed multiple nuclei, 
marginated chromatin, prominent nucleoli, randomly arrayed actin and myosin filaments and 
rudimentary Z-banding (Figure 4.9). Degenerate muscle cells with clumped chromatin, prominent 
nucleoli, disrupted cytoplasmic myofibrils, vacuolation, distended mitochondria (M) and lipofuscin 
were also present (Figure 4.10). 
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Fig 4.1. A light photomicrograph showing normal skeletal muscle from a control subject (H&E x 200). 
Fig 4.2. A light photomicrograph showing prominent atrophy, hypertrophy and split fibres. There are 
occasional central nuclei and capillaries with very thick walls can be seen. 
(H&E x 200) 
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Fig 4.3. A NADH stain showing moth-eaten Type I fibers. Note that the atrophy and hypertrophy affects both 
skeletal muscle fiber types. (NADH x 120). 
Fig 4.4. Electron micrograph showing a loss of myofibrils (arrows), prominent subsarcolemmal and 
intermyofibrillar glycogen (G) and swollen mitochondria with lost cristae (arrow heads). ( x 5500) 
63 
64 
Fig 4.5. Electron micrograph of myelin whorl formation within the mitochondria (arrows). (x 72000) 
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Fig 4.6. Electron micrograph of a subsarcolemmal filamentous body (arrow). (x 44000) 
Fig 4.7. Electron micrograph showing a loss of myofilaments and z-bands (arrows), glycogen aggregates 
(G), subsarcolemmal lipid droplets (L), sarcolemmal folding (arrow head) and increased interstitial collagen 
(C). (x 10500) 
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Fig 4.8. Electron micrograph of a capillary with a thickened, multilayered basement membrane 
(BM) containing debrinous material (arrow). 
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Fig 4.9. Electron micrograph of a myoblastic cell containing actin and myosin filaments, rudimentary z-
bands (arrow) enveloped within a continuous basal layer. (x 44000) 
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Fig 4.10. Electron micrograph showing a degenerate muscle cell with clumped chromatin, prominent 
nucleolus, disrupted cytoplasmic myofibrils, vacuolation, distended mitochondria (M) and lipofuscin (L). 
(x 22000) 
Fig 4.11 Electron micrograph of muscle from one of the controls showing normal sarcomeric units, 
mitochondria, and capillary basement membrane (arrow). (x 14000) 
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Electron microscopic analysis showed that of the samples from the eight control subjects, five had 
normal ultrastructural features (Figure 4.1 O); the myocytes contained smoothly outlined nuclei with 
evenly dispersed chromatin and nucleoli of normal size. The mitochondria were regular in shape 
and size, and small subsarcolemmal aggregates were occasionally seen. The myofibrils were 
aligned and the sarcomeric units showed regular A, Z, H, M and I banding. Glycogen granules 
were evenly dispersed throughout the cells and no large accumulations were present. The lipid 
droplets were of normal size and distribution, and were usually situated near the mitochondria. The 
sarcoplasmic membranes and overlying basement membranes were continuous and evenly 
contoured (Figure 4.11 ). 
The muscle sample from one control subject revealed foci of myofibrillar loss and an occasional 
swollen mitochondrion, another had numerous lipid droplets, subsarcolemmal mitochondrial 
aggregates, and increased glycogen content while a third showed swollen mitochondria. 
Ultrastructural morphometry of the controls revealed capillary basement membrane widths varying 
from 99 to 157 nm with a mean (± SEM) of 121 ± 3 nm (p<0.01 vs. CHF). 
Relationship of exercise performance to skeletal muscle pathology scores 
The grading of the skeletal muscle biopsy specimens showed that patients with CHF had 
significantly higher scores for myopathic changes compared to the controls (12.2 ± 5.1 vs. 1.6 ± 
2.0 arbitary units; p<0.03; Table 4.5). 
Correlation analyses were performed between the skeletal muscle pathology score, ejection 
fraction and the other variables of peak exercise performance (described in Chapter 3) in the 
patients with CHF. Table 4.5 shows that there was no significant correlation between the skeletal 
muscle pathology score and the resting ejection fraction, peak torque generated by the quadriceps 
muscles, MVC or time to fatigue during repetitive maximal isometric contraction/relaxation cycles. 
There was also no correlation between the ejection fraction and either Wlpeak or V02 peak or any 
other tests of skeletal muscle function (r = 0.12-0.32; NS). 
,. 
"' 
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Ta ble 4.4. Correlation coefficients for skeletal muscle pathology score, ejection fraction and peak exercise 
iables in patients with heart failure. var 
Variable rValue PValue 
Eie ction fraction %) -0.30 NS 
VO -0.64 <0.05 
WL peak (W) -0.72 <0.05 
PK TQ (Nm) -0.5 NS 
PK TQ/L TV Nm/cc) -0.05 NS 
PK TH (Nm) -0.59 NS 
PK TH/LTV (Nm/cc) 0.53 NS 
TW Q (J) -0.62 <0.05 
TW Q/L TV (J/cc) -0.58 NS 
TW H (J) -0.49 NS 
TW H/L TV ( J/cc) -0.56 NS 
MV C (Nm) -0.52 NS 
MV C/L TV (Nm/cc) -0.60 NS 
TI F -0.50 NS 
Abbr eviations: V02 peak, peak oxygen consumption; Wlpeak, peak work load; PKTQ, peak torque of the quadriceps muscles; 
PKT 
produ 
H, peak torque hamstring muscles; W, watts; LTV, lean thigh volume, Nm, Newton metre; cc, cubic centilitre; TWQ, total work 
ced by the quadriceps muscles and (TWH) total work produced by the hamstring muscles during 25 maximal isokinetic 
actions; J, joules; MVC, maximum voluntary contraction; TTF, time to fatigue. contr 
Ho wever, a significant correlation was found between the pathology score and both the V02 peak 
-0.64; p<0.05), Wlpeak (r = -0.72; p<0.05) and total work performed by the quadriceps (r = 
mus cles during 25 maximal isokinetic contractions. 
/ 
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Discussion 
The first important contribution of this study is to describe the nature of the changes which were 
prominent on light and electron microscopy in skeletal muscle samples in patients with severe 
CHF. Light microscopic changes included fibre splitting, fibre degeneration and regeneration, 
nuclear knots and chains, increased content of lipid droplets, and interstitial oedema. Fibre 
splitting, which was a consistent finding, has been identified in hypertrophied fibres and also in 
normal subjects following training, and is a sign of regeneration following muscle cell degeneration 
(Edgerton 1970). It has been hypothesized that the greater workload per remaining fiber and the 
greater associated metabolic stress may cause fibre splitting (Mancini et al. 1992; Francis et al. 
1985). Since these patients are largely sedentary, these phenomena may be a consequence of 
prolonged inactivity of the skeletal muscles. 
The presence of moth-eaten Type I fibres may be a reflection of a reduced oxidative capacity. In 
NADH preparations, moth-eaten fibres are seen with disruption and distortion of the 
intermyofibrillar network especially in zones of poor enzyme activity. Electron microscopy revealed 
mitochondrial and myofilamentous changes in these patients. Drexler et al. (1988) also reported a 
reduced number and size of mitochondria in patients with CHF, as well as a diminished number of 
mitochondrial christae, a finding consistent with diminished oxidative enzyme capacity. These, as 
well as excessive intra-cellular lipid deposition and variation in muscle fibre areas found in our 
analysis are not specific to any single muscle disorder. Similar findings have been reported in 
physically-active renal patients studied in this laboratory (Diesel et al. 1993). 
Filamentous bodies were found in two of the three patients with mitochondrial inclusions. 
Teravanen and Makite (1977) found the proportion of mitochondrial myelin inclusions increased in 
proportion to the severity of clinical symptoms in patients with intermittent claudication. A similar 
relationship was found for decreased glycogen content. increased lipofuscin content and greater 
myofibrillar degeneration. 
Severe capillary basement membrane thickening was also observed in these patients. Thickening 
of the basement membrane in capillaries in the pronator teres muscle (Longhurst et al. 1975) and 
in skin (Wroblewski et al. 1992) in patients with CHF shows that this disorder is widespread. 
Thickening of basement membranes has been described in patients with diabetes mellitus (Vracko 
1970; Zacks et al. 1962), but the thickness of each membrane measured only between 80-200 11m 
(lacks et al. 1962), whereas in the present study, basement membrane thicknesses were in the 
range of 194 to 840 11m. 
Atrophy of both Type I fibres (Lipkin et al. 1988; Sullivan 1990a; Poole-Wilson et al. 1988) and 
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Type II fibres (Lipkin et al. 1988; Dunnigan et al. 1987; Poole-Wilson et al. 1988) have previously 
been reported in patients with CHF. We found that hypertrophy of both fibre types was also present 
and affected over 60% of all fibres in two patients. 
Previous studies have reported an increased proportion of Type II fibres in patients with CHF 
(Sullivan 1990a; Lipkin et al. 1988; Mancini et al. 1989; Drexler et al. 1992). However, only two 
patients in this study showed Type II muscle fibre predominance and the difference in% Type II 
fibres between the groups was only 9%. 
Whilst the above findings pertain to biopsy samples from the vastus lateralis muscle, similar 
histological abnormalities have been described in the pronator teres (Longhurst et al. 1975), 
deltoid and paraspinal (Smith et al. 1976), and diaphragmatic (Arora and Rochester 1982; 
Thurlbeck 1978) muscles in these patients. These findings suggest that this myopathic disorder is 
indeed widespread and involves both the large and small muscle groups. The mechanism 
underlying these structural abnormalities is unknown. Changes in skeletal muscle histology 
including Type I atrophy, fibre splitting, irregular shaped fibres, disintegrated fibrils, streaming z-
lines, vacuolar degeneration and increased lipid deposits in the interfibral space have been 
described in patients after prolonged periods of immobilization (Appell 1990). Although it may be 
argued that the changes seen in the skeletal muscle of the patients in this study might be due to 
relative inactivity and deconditioning, it is important to consider that the patients in this study were 
only included if they were not bed-ridden and could participate in exercise testing. In addition, 
hypertrophy was a significant associated feature in many samples. Thus, the effects of prolonged 
bedrest were not assessed. Rather, our findings suggest that inactivity-induced atrophy cannot be 
the sole cause of skeletal muscle abnormalities in these patients. Poole-Wilson et al. (1988) 
reported that many histological abnormalities seen in patients with CHF are not typical of the 
changes seen as a result of either prolonged bed rest or of reversible ischaemia caused by 
peripheral vascular disease. Similar histological abnormalities have been described in 
asymptomatic physically active patients with hypertrophic cardiomyopathy (Smith et al. 1976) and 
with arrythmias (Dunnigan et al. 1987). It is therefore probable that deconditioning alone is not 
responsible for the changes described in these patients. 
,. 
It could be argued that the numerous medications ingested by the patients with CHF could also 
add to the abnormalities of skeletal muscle histology. However, similar structural changes in 
skeletal muscle have been described in asymptomatic young patients with cardiomyopathy who 
were not on any medications (Smith et al. 1976). It is therefore unlikely that our findings can be 
explained on the basis of a drug effect. 
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The second important finding was to show that whereas the ejection fraction, an index of central 
cardiovascular performance, could not predict the exercise capacity of these patients, the severity 
of skeletal muscle pathology significantly predicted exercise tolerance (Table 4.4). Others (Port et 
al. 1981, Baker et al. 1984) also found no significant relationship between the ejection fraction and 
exercise tolerance in patients with CHF. 
The severity of the skeletal muscle pathology correlated best with exercise performance measured 
as Wlpeak rather than V02 peak. This is also found in the healthy athletic population (Hawley and 
Noakes 1992). Drexler et al. (1992) have previously reported a significant relationship between 
peak exercise performance and decreased mitochondrial density and reduced surface area of 
mitochondrial cristae. These authors also reported that this relationship remained even when 
exercise performance improved with medication. 
There was also no relationship between the ejection fraction and the severity of skeletal muscle 
pathology, highlighting the possibility that factors other than impaired central haemodynamic 
function may contribute to the myopathy. 
In summary, this study provides evidence that severe skeletal muscle structural alterations exist 
and could perhaps contribute to the exercise intolerance in patients with CHF. 
Conclusions 
Future research should aim to determine the mechanism(s) and time course of these changes, so 
that effective management policies can be introduced to prevent the development and progression 
of the myopathy. 
CHAPTER 5 
SUMMARY AND CONCLUSIONS 
76 
Summary 
The first aim of this thesis was to evaluate the exercise capacity and skeletal muscle function in 
patients with CHF awaiting heart transplantation, and secondly to describe the histological and 
ultrastructural findings in skeletal muscle biopsy samples from these patients. The third aim was to 
develop a simple histological grading system to quantify the magnitude of changes in skeletal 
muscle and determine if a relationship exists between these changes and the exercise capacity of 
these patients. 
The first study of this dissertation, reported in Chapter 3, established that the V02 peak, WL peak, 
and total work performed by the quadriceps and hamstring muscles in a 30 second isokinetic test, 
maximum voluntary contraction and time to fatigue during a test of isometric endurance were lower 
in patients with CHF compared with controls. Furthermore, patients with CHF stop exercising at 
lower heart rates, rates of 02 consumption and ventilation, and at low blood lactate concentrations 
compared with control subjects. These findings are compatible with the interpretation that skeletal 
muscle limits the exercise tolerance of these patients but that this is not due to a more rapid 
,. increase in blood lactate concentrations in patients than in controls during exercise. 
The study reported in Chapter 4 showed that significant histological and ultrastructural changes 
were found in all skeletal muscle biopsies from patients with CHF. These changes included 
atrophy and hypertrophy of fibres, fibre splitting, internalized nuclei, nuclear knots, moth-eaten 
fibres, increased lipid droplets. Electron microscopy showed a large variety of nonspecific 
abnormalities, including mitochondrial changes, Z-band degeneration and accumulation of 
intracellular glycogen. Ultrastructural morphometry revealed capillary basement membrane width 
significanfly increased in the skeletal muscle of patients with CHF. A novel, blinded, impartially 
scored method for grading skeletal muscle pathology showed that skeletal muscle biopsies of 
patients with CHF had higher scores for myopathic cnanges compared to controls. Skeletal muscle 
pathology score correlated significantly with V02 peak, Wlpeak, and TWQ, but not with EF%. 
EF% however did not correlate with either V02 peak, Wlpeak or TWQ. 
Conclusions 
This thesis c.onfirms that severe structural abnormalities exist in patients with CHF and may limit 
exercise capacity in these patients. In addition, patients with CHF have altered skeletal muscle 
function, including a decreased resistance to fatigue. 
77 
During graded exercise to exhaustion, patients with CHF seem to be limited by peripheral rather 
than by central, cardiovascular factors. This was suggested by the finding that graded exercise to 
exhaustion is terminated at lower heart rates, rates of 02 consumption, ventilation and blood 
lactate concentrations in patients compared with controls. 
All skeletal muscle biopsies from patients with CHF showed both histological and ultrastructural 
abnormalities. 
Furthermore, the severity of the skeletal muscle pathology but not the resting systolic cardiac 
function, predicts exercise performance in patients with CHF.This finding highlights the possibility 
that factors other than impaired central haemodynamic function may contribute to the skeletal 
myopathy. 
Future research should aim to determine the mechanism(s) and time course of these changes, so 
that effective management policies can be introduced to prevent the development and progression 
of the skeletal myopathy of patients with CHF. 
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